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Abstract 
Although the negative health impacts of obesity have been well documented, the number of 
overweight and obese patients has and is predicted to continue rising. One of the causal 
factors of obesity is a constant positive energy balance mainly from excessively high caloric 
intake from food compared with limited physical activity (caloric expenditure). While this 
basic concept is well understood, the specific changes that obesity invokes within the body 
have not been fully uncovered and thus a molecular reversal of obesity has not been achieved 
to date. Along the way to identify a pharmaceutical target, a new type of fatty tissue, brown 
adipose tissue (BAT), has moved into the focus with potential therapeutic implications.  
In contrast to white adipose tissue (WAT) that serves as long-term fat storage in the form of 
neutral lipids, BAT uses these molecules as fuel to perform non-shivering thermogenesis, a 
process seen most commonly in hibernating animals and infants, and used to keep the body 
core temperature stable. Since BAT function is very different from WAT function, the two 
tissue types are often studied in conjunction in order to better identify the characteristics and 
the possibility to increase BAT activity and mass in obese adults (as a way to increase 
“parasympathetic” caloric expenditure).  
This thesis work aims to investigate adipose tissue (AT) physiology on different levels: from 
interactions of isolated adipose-derived stem cells (ADSC) with matrices to the function of 
AT in mice. Special focus is directed towards the molecules at the center of adipose tissue 
physiology: triacylglycerols (TAGs). These are often neglected during analysis due to the 
difficulty to study them in a cellular context. Classical methods, like gas chromatography, 
usually rely on extraction of all lipids from a tissue depot requiring extensive sample 
preparation. Magnetic resonance imaging or matrix-assisted laser desorption/ionization 
followed by mass spectrometry imaging can be used to visualize lipids in their natural setting 
but do not offer high enough resolution or require extensive sample preparation. Thus, in this 
work, I focused on using a label-free chemical imaging approach called coherent anti-Stokes 
Raman scattering (CARS) microscopy to study TAGs in situ at increasing levels of biological 
complexity. This method requires almost no sample preparation and can visualize sub-
micrometer-sized TAG storage depots based on their intrinsic chemistry. 
First, CARS microscopy was used to follow ADSC during the early stages of attachment and 
interaction with an extra cellular matrix (ECM); then CARS was employed to follow lipid 
accumulation during adipogenic differentiation to study how the ECM structure affects that 
process. Next, mature adipocytes were studied in ex vivo tissue sections. During this study 
mitochondrial activity was also investigated. In the following studies, not only the 
volume/number of lipid depots was of interest but also their contents. Therefore, we extended 
the CARS imaging with a spectral dimension, developing a new method to generate maps of 
TAG chain length and saturation, which were then be employed to see how high fat diet 
affects the lipids in BAT and WAT.  
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Abbreviations 
 
Related abbreviations in alphabetical order or grouped. Gene/protein names and symbols 
used in equations are summarized in the next section. 
 
2D  two dimensional 
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 TEM transmission electron microscopy 
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FDA  Food and Drug Administration 
FDG PET  fluordesoxyglucose positron emission tomography  
G3P  glycerol-3-phosphate 
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IBMX  3-isobutyl-1-methylxanthine 
LCST  lower critical solution temperature 
LD  lipid droplet 
LDL  low density lipoprotein 
 VLDL very low density lipoprotein 
MALDI-
MSI 
 matrix-assisted laser desorption/ionization mass 
spectrometry imaging 
xiv 
 
MPEF  multi photon excited fluorescence 
 OEPF one photon excited fluorescence 
MRI  magnetic resonance imaging 
NRB  non-resonant background 
OECD  Organization for Economic Co-operation and 
Development  
PCL  polycaprolactone 
PDMS  poly(dimethylsiloxane) 
RGD  amino acid sequence: arginine-glycine-aspartic acid 
Rho123  Rhodamine 123 
SC  stem cells 
 (h/r)ADSC (human/rat) adipose-tissue derived stem cells 
 ESC embryonic stem cells 
 MSC mesenchymal stem cells 
SHG  second harmonic generation 
SRS  stimulated Raman scattering 
T2D  type II diabetes 
TGF  transforming growth factor 
THG  third harmonic generation 
WHO  world health organization 
WT  wild-type 
 KO knock-out 
 TG transgenic 
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Genes and Proteins 
 
AGPAT2 1-acylglycerol-3-phosphate-O-acyltransferase 
ATGL adipose triacylglyceride lipase (same as PNPLA2) 
BMP7/8B bone morphogenic protein 7/8B 
C/EBPs CCAAT-enhancer-binding proteins (CCAAT = nucleotide sequence) 
CPT1 carnitine palmitoyltransferase 1 
DGAT1/2 acyl-coenzyme A (aycl-CoA):diacylglycerol acyltransferase 1/2 
EBF2 early B-cell factor 2 
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FGF21 fibroblast growth factor 21 
GPAM glycerol-3-phosphate acyltransferase, mitochondrial 
GPD1 glycerol-3-phosphate dehydrogenase 1 
HSL hormone-sensitive lipase (same as LIPE) 
LIPE lipase E, hormone-sensitive type 
LPL lipoprotein lipase 
MCP1 monocyte chemoattractant protein 1 
MYF5 myogenic factor 5 
PCK1 phosphoenolpyruvate carboxykinase 1 
PGDFRA platelet-derived growth factor receptor alpha 
PNPLA2 patatin like phospholipase domain containing 2 (same as ATGL) 
PPARȖ peroxisome proliferator-activated receptor gamma 
PPARGC1A PPARȖ coactivator 1 alpha 
SCD1/2 stearoyl-CoA desaturase 1/2 
SREBF1c sterol regulatory element binding factor 1c 
STE20 sterile 20 kinase superfamily 
STK25 serine/threonine protein kinase 25 
UCP1 uncoupling protein 1 
VEGF vascular endothelial growth factor 
 
 
Throughout this thesis gene/protein nomenclature for mice is used. With gene names starting 
with uppercase letters and italicized while proteins are all uppercase and non-italicized.  
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1  Introduction 
 
Obesity and the associated metabolic syndrome have become some of the most pressing 
concerns for world health during the 21st century. With an estimated 39% of all adults 
worldwide classified as overweight (13% obese), health care systems face extended 
challenges to cope with this scenario [1]. Cardiovascular diseases, which obese patients are 
prone to develop, are the leading cause of death worldwide, especially in developed 
countries. Concurrently with the development of this health crisis, our understanding of the 
underlying changes that obesity causes within the body has continued to grow. This includes 
our insight into the role and function of the main involved tissue during obesity – the fat, or 
adipose tissue (AT). During the last 15 years, there has not only been a revolution from 
seeing the AT as inert mass of fat to classifying it as an endocrine organ [2], but also two new 
types of AT have been described in human adults [3], [4]. This increased awareness has also 
opened further questions about the basic function and physiology of AT. In order to answer 
some of these questions, different levels of model systems have had to be established. On the 
first level are cells: isolated mature adipocytes, stem cells, and cell lines that allow well-
defined intervention with known stimulating factors. The second level is studies on a whole 
organism – murine or human – to see the interaction between ATs and other parts of the 
metabolism.  
However, it is not only crucial to develop model systems mimicking the effects of obesity, 
but the concurrent advancement of analysis techniques is fundamental to improve our 
understanding of these systems. So far the focus has been on techniques that analyze whole 
populations of cells or a whole tissue. Similar to the revolution in personalized medicine, 
such a holistic analysis could potentially mask the existence of distinct sub-populations, 
which may hide in the average behavior. Since this has been understood, single-cell analysis 
techniques have experienced a boost in development [5]. During my doctoral studies I 
contributed to this field with the development of molecular microscopy tools to study 
adipogenic differentiation of stem cells (Paper II), the metabolic state of AT (Paper III), 
and the chemical investigation of lipid species in situ in cells or tissue (Paper IV).  
In addition to the development of microscopic tools, I also employed these techniques to 
answer physiological questions about the interaction of stem cells with complex environment 
in vitro (Paper I & II), and the impact of kinases or nutrition on lipid composition in ATs 
(Paper III & V).  
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Structure of the thesis 
Following this brief introduction, Chapter 2 establishes a deeper background on adipose 
tissue biology, pathological changes during obesity, and in vitro adipogenesis. Chapter 3 
focuses on tools for in situ analysis of adipocyte physiology, metabolic activity, and lipid 
chemistry and the physics of nonlinear microscopy as relevant for this thesis work. In 
appropriate places the contributions from Paper I, II, III, & IV to the analytical methods of 
AT biology are highlighted. In this way, the applications of nonlinear microscopy methods to 
biological question are established prior to Chapter 4, which focuses on the biological results 
from paper I, II, III, & V. Finally, I present a brief conclusion in Chapter 5 with an outlook 
for where my research can lead.  
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2  Adipose Tissue Biology 
 
Obesity - a threat to health worldwide 
During the past 100 years our daily lives have undergone dramatic changes: the majority of 
the work force is now employed in an office setting with only light physical activity 
throughout the day [6] while at the same time the calorie intake has risen markedly [7]. These 
two factors seem to have played a key role in the increased prevalence of obesity, essentially  
being overweight to a degree that it causes medical complications, around the world [8]. 
Other factors causing an imbalance in energy intake vs. expenditure are genetic or medical 
[9]. Today, more than one in two adults and almost one in six children are classified as 
overweight or obese in OECD (Organization for Economic Co-operation and Development) 
countries (Figure 1A) [10]. A further increase of the obesity rates is predicted (Figure 1B) 
and social inequalities are a strong risk factor – less-educated women are three times more 
likely to be overweight than those with higher level of education [10]. Other risk factors are, 
e.g., poverty, stress, and poor diet [11]. Both the World Health Organization (WHO) and 
OECD define overweight with a body mass index (BMI, weight height-2) of ≥ 25 kg m-2 and 
obesity ≥ 30 kg m-2. Other classifications like a body fat (BF) percentage of > 25% in men 
and > 35% in women have been suggested [12]. BMI has high specificity but low sensitivity 
compared to BF-detected obesity, i.e., the identification of true positives is >97% while more 
than 50% of people with excess body fat are wrongly qualified with a non-obese BMI [13], 
[14].  
 
Figure 1. Obesity worldwide. (A) Prevalence of obesity among women and men. Data collected by 
OECD 2012-2015. (B) Development of obesity rates during the years with predicted trends for until 
2030 assuming a linear increase. Data reproduced with permission from OECD(2017), Obesity 
Update [10].  
2  Adipose Tissue Biology 
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Only with the BF definition, patients with normal weight obesity, i.e., those who have a 
normal BMI but increased body fat and at the same time display metabolic dysregulation, are 
included [15].  
The occurrence of interconnected physiological, biochemical, clinical, and metabolic factors 
that increase risk of type 2 diabetes (T2D), atherosclerotic cardiovascular disease, and 
mortality, are summarized as the concept of metabolic syndrome [16]. There are several 
different combinations of symptoms and risk factors for obesity, although no cohesive view 
has been agreed upon, as summarized by Kaur [16]. Additionally, the increased risk for 
morbidity and the rise in obesity also puts a strain on healthcare systems [11]. 
Much research is devoted to the identification of dietary, environmental, biochemical, and 
molecular factors contributing to the development and ultimately to the early prevention of 
obesity. However, there is also strong interest in the changes human bodies undergo en route 
to obesity development and with that interest, searching for a possible course to revert to 
better metabolic health in obese individuals. To date the most effective treatment for obesity 
is weight loss induced by bariatric surgery [17]. If compared to lifestyle intervention, such as 
exercise plans and dietary changes, the weight loss after surgery is higher and more often 
sustained. Moreover, surgery resolves the metabolic syndrome more effectively [18]. In T2D 
patients, one of the major advantages of surgery is the resolution of the insulin dependence 
after surgery in 82% of all patients, with 62% remaining diabetes free after two years [17]. 
Other studies have confirmed that bariatric surgery improves patient health for over 10 years 
[19]. Although the weight loss seems to play a role for the resolution of T2D [17], there are 
other cases, where T2D clears within days of bariatric surgery [20]–[22], highlighting the 
interconnection among weight, hormones, and signaling found within the body. The fact that 
the insulin dependent T2D resolves before the BF can change, demonstrates the complexity 
of studying disease mechanisms with human patients as an apprehension on top of the ethics 
limiting the possibility for intervention in humans and with that the search of specific cellular 
and molecular targets.  
In order to study a disease with so many involved tissues, interconnected signaling pathways, 
and an unclear dominant symptom, it is crucial to work with model systems where specific 
features can be isolated, while also considering the disease at the whole organism and 
population level. This allows forming correlative relationships between specific tissues/cells 
and aspects of obesity and T2D. For example, while the analysis of groups of the human 
population helps the identification of contributing factors, which could be the basis for 
potential early intervention programs or nutritional recommendations, it is nearly impossible 
to isolate specific molecular factors and establish a single line of treatment for all cases due to 
large heterogeneity between patients. For that purpose, animal models can allow a higher 
degree of control over, e.g., nutrition and exercise. Mice (Mus musculus), and other animals 
like Drosophila melanogaster and Caenorhabditis elegans, offer an opportunity to decipher 
the interplay of different organ systems and what effect lipids or sugars have on a whole 
organism. Nevertheless, it is still extremely challenging to understand the function of 
individual tissues or cell types in vivo in animal models.  
Obesity - a threat to health worldwide 
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Figure 2. Three types of adipocytes. The morphological differences between the three types of 
adipocytes (from left to right: white, beige, brown) are the number of lipid droplets and mitochondria. 
They also differ in linage origin, gene expression, and function.  
 
 
Figure 3. Adipose tissue depots in mouse and human. Both mice (A) and humans (B) have 
interscapular or cervical depots of brown adipocytes, respectively. Inguinal WAT in mice is 
comparable to subcutaneous WAT in humans, while gonadal (mice) is similar to visceral (human, not 
depicted). Reprinted with permission from [23]. 
2  Adipose Tissue Biology 
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For this reason, in vitro cell cultures are better suited to establish specific cell-type responses. 
Given the broad impact and complexity of studying obesity, a combination of data from 
different model systems is essential to further the molecular and physiological understanding 
of obesity. 
 
Three types of adipocytes 
Adipose tissue (AT), or fat, with its metabolic pathways and gene products has evolved from 
invertebrate origins into lower vertebrates to mammals and birds. Fat is present in all 
mammals and consists of several depots around the body. AT can be fundamentally separated 
into two types - white (WAT) and brown (BAT) - according to their function for either 
energy storage or dissipation, respectively. Although there are two fundamental ATs, there 
are three types of adipocytes as shown in Figure 2. 
White adipose tissue 
WAT has its origin in the mesenchymal stem cell (MSC) linage, which also gives rise to 
myoblasts, chondroblasts, and osteoblasts [24]. It is the most plastic of the metabolically 
active tissues, i.e., tissues that generate bioactive molecules and have a high oxygen 
consumption, and can contribute to 5-60% of the total body weight, depending on the 
nutritional status [25].  
WAT is split into several depots, with some differences in function. The locations of the 
depots are either below the skin, the so called subcutaneous fat, or deeper in the abdomen, the 
visceral AT [26]. The most used pre-clinical model to study AT development and pathology 
are rodents (most often mice and rats); thus, it is important to be aware of similarities and 
discrepancies between rodents and humans [27]. There are differences in the distribution of 
the fat depots between mice (and rats) and humans (Figure 3), as well as the number of 
layers that can be found in the subcutaneous AT. Still, the inguinal WAT (iWAT) in mice, 
spreading from dorsolumbar to gluteal region, is seen as most similar to the gluteofermoral 
subcutaneous AT in humans. For studies aiming at human visceral AT depots, the mesenteric 
fat pad, along the intestines in mice, would be best suited but due to larger volume and 
possibility of surgical manipulation the (peri)gonadal fat pad (gWAT) is used more common 
[27]. The accumulation of excess visceral AT is known to correlate with the afore-mentioned 
metabolic syndrome, while subcutaneous AT, especially on the legs, does not seem to raise 
the risk [28]. 
Both rodent and human WAT consist of several cell types, including stem cells, adipocytes, T 
cells, B cells, and stromal-vascular cells (Figure 4). Stem cells from WAT have been 
recognized as an important supply for mesenchymal differentiation lineages in vitro [29]–
[31].  
Three types of adipocytes 
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Figure 4. Inguinal white adipose tissue from mice. Ex vivo iWAT stained for active mitochondria 
(green, MPEF, Rho123). Lipids (CARS, 2845 cm-1) are shown in magenta, fibrillar collagen (SHG) is 
shown in cyan. Blood vessels are marked with arrow heads, non-adipocyte cells with stars, and nuclei 
circled. Scale bars: 40 and 10 μm.  
 
 
Figure 5. Interscapular brown adipose tissue from mice. Ex vivo BAT stained for active 
mitochondria (green, MPEF, Rho123). Lipids (CARS, 2845 cm-1) are shown in magenta. Blood 
vessels are marked with arrow heads, non-adipocyte cells with stars, and nuclei circled. Scale bars: 
40, 25, 15, and 10 μm.  
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They contribute 15-50% of all cells in AT [32]. Mature adipocytes in vivo are filled by a 
single large fat storage compartment called a lipid droplet (LD), occupying ~ 90% of the cell 
volume and forcing all cellular organelles into close proximity of the plasma membrane 
(Figure 2 & 4) [26]. These LDs are dynamic storages for neutral esters of fatty acids (FAs), 
which are often toxic to (when non-esterified) but needed to readily supply energy to most 
cells in the body [33]. WAT acts as a buffer for plasma non-esterified fatty acids (NEFAs) 
and TAG levels in order to avoid ectopic lipid build-ups (lipotoxicity) [34]. Lipotoxicity is 
based on the observation that lipid-derived metabolites and the accumulation of LDs in non-
lipid storing tissues (ectopic lipids in, e.g., pancreas, heart, blood vessel walls) causes 
impaired insulin-stimulated glucose transport, diminished insulin secretion, mitochondrial 
malfunctioning, endoplasmic reticulum (ER) stress, accumulation of reactive oxygen species, 
and cell death [35], [36]. In contrast to this, it has also been observed that some intra-
muscular lipid storages (in athletes) can lead to increased insulin sensitivity and these 
beneficial properties might be linked to changes in lipid composition and turnover [37].  
Moreover, as an endocrine organ, WAT is involved in glucose homeostasis and immune 
response, affecting development of infectious diseases and cancer, through the release of 
adipokines (cell-signaling proteins) [25]. The expression and secretion of some of these 
adipokines can be induced by nutrients in both humans and rodents [27]. These proteins 
regulate diverse processes, e.g., whole-body energy homeostasis, angiogenesis, blood 
pressure, and hemostasis [38]. 
Brown adipose tissue 
BAT, in contrast to WAT, is a thermogenic organ, found in almost all eutherian (placental) 
mammals except in, Sus scrofa domesticus (domestic pigs) [39], [40]. Other mammal classes, 
monotremes (egg-laying mammals) and marsupials (pouched mammals), possess no BAT 
[41]. BAT contributes to almost half of all oxygen consumed in cold-adapted mammals, i.e., 
animals that have been exposed to low temperatures for a prolonged time frame [42]. BAT 
has been studied for a long time in rodents, but evidence of its presence in adult humans only 
emerged in the last 10 years in seminal studies using F-18 FDG PET (Fluorodesoxy positron 
emission tomography) [43]–[49]. However, not all adults seem to have active BAT; the 
prevalence rates range from 30-95% depending on the study, as reviewed by Nedergaard, 
Bengtsson, and Cannon [50]. Within the BAT-positive patient group the thermogenic 
activity/capacity also varies. Without activation, the main depots for BAT in adult humans 
are found in the cervical, supraclavicular, axillary, and paravertebral regions, and the areas 
can be expanded under noradrenergic stimulation [42]. In rodents and human infants the 
major BAT depot is found in the neck, interscapular region (Figure 3), and a smaller depot in 
the perirenal region. Rodents keep their BAT depots throughout their life [51]. Additionally 
to the role in non-shivering thermogenesis, it has also been suggested that BAT might have a 
similar endocrine role as WAT [52]. Moreover, BAT contributes to 50% and 75% of whole-
body TAG and glucose clearance from circulation shortly after a meal in mice [53].  
Three types of adipocytes 
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Adipocytes in BAT display several small LDs and are packed with mitochondria (Figure 2 & 
5) in stark contrast to WAT adipocytes. The inner membrane of these mitochondria contains 
the uncoupling protein 1 (UCP1), which short circuits the ATP production in the respiratory 
chain by dissipating the proton gradient, thus allowing direct heat production from fatty acid 
oxidation. The brown adipocyte activity is controlled by nerve fibers and BAT is highly 
vascularized (Figure 5), so the substrate for heat production, oxygen and lipids, can be 
readily supplied [54]. These capillaries can also carry heat produced in BAT to other parts of 
the body. Similarly to WAT, BAT also contains stem cells, which play an important role for 
BAT expansion during increased thermogenic demand. For a long time, a common stem cell 
source was presumed for brown and white adipocytes, since both cell types contain 
significant LDs. However, it is now known that brown adipocytes develop from precursor 
cells expressing Myf5 and are part of the dermomyotomal lineage, which also give rise to 
skeletal muscle cells [55]. Consistent with this common precursor, the gene signature [56] 
and mitochondrial proteome [57] is similar between BAT and skeletal muscle.  
The total thermogenic capacity of BAT at any given time is determined by the mitochondrial 
density and amount of UCP1 in the cells and on cell number, which is in turn controlled by 
the rates of proliferation and apoptosis. While the amount of UCP1 can be controlled within 
minutes, the recruitment of new cells needs days/weeks of constant stimulation. The number 
of brown adipocytes increases after cold stimulus and can also be increased with chemical 
stimulus such as norepinephrine, the most important and well-studied signaling molecule in 
BAT [42]. Other factors are FGF21 (secreted by liver, BAT), irisin (muscle), VGEF (blood 
vessel, BAT), T4 (Thyroid), natriuretic peptides (heart), BMP8B (BAT), orexin, and BMP7 
[55]. The cellular sources for orexin and BMP7 are unknown. Norepinephrine is an 
endogenous signaling mediator in the autonomous nervous system that interacts with three 
types of adrenergic receptors (AR) of which the most significant in rodents is the ȕ3-AR 
stimulation. In humans, the ȕ3-AR is found in WAT, BAT, gallbladder, and to a much lower 
extend in the colon [58]. Thus, efforts have been made to target this receptor specifically and 
develop anti-obesity drugs by exploiting the localization of the receptor [59], [60]. Due to 
low oral bioavailability and undesirable cardiovascular effects that stem from cross-reactivity 
with ȕ1-AR, none of the tested drugs so far have made it past clinical trials. However, now 
there is a promising candidate drug, which has been approved for treatment of an overactive 
bladder [61].  
Another way to stimulate brown adipocyte recruitment is chronic cold exposure to 
temperatures below “the lower critical temperature of the thermoneutral zone”, which for 
most mammals lies close to 30°C [42]. During short-term cold exposure the body core 
temperature can be kept constant with shivering, but if the cold exposure becomes chronic 
non-shivering thermogenesis in BAT takes over. This leads to an activation of PPARGC1A 
(PPARȖ coactivator 1 alpha), which leads to the induction of genes involved in UCP1 
dependent thermogenesis and to mitochondrial biosynthesis [62]. Nedergaard, Bengtsson, and 
Cannon hypothesize that this activation could be used as anti-obesity treatment and that rising 
room temperatures and availability of warm clothes could have contributed to the increase in 
obesity rates [50]. In connection with investigation of cold activation on BAT, it could also 
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be established that BAT activity correlates negatively with age, BMI, and yearly season: 
there is generally less BAT in older subjects, BAT-positive subjects were more likely to have 
a low BMI, and reduced BAT activity would occur in summer [63]. Some studies indicate 
that there might be more BAT in females than in males. However, Nedergaard, Bengtsson, 
and Cannon speculate that this might be due to a difference in temperature perception of 
women vs. men, and thus different levels of BAT activation during clinical evaluation of 
BAT mass [50].  
Beige adipocytes 
There is a population of adipocytes in WAT, which can express Ucp1, and show increased 
UCP1 protein levels, upon stimulation, and hence acquire brown-like features [64], [65]. 
During the recent years, this cell type have been set apart from classical brown adipocytes 
and termed “recruitable”, “brite” (brown in white), or beige adipocytes [4]. The latter term is 
more common than the others and will be used exclusively throughout the rest of this thesis. 
These cells have an appearance similar to brown adipocytes, with multiple LDs and high 
mitochondrial activity [66].  
Table 1. Differences and similarities of the three types of adipocytes [67], [68]. 
 
 
 
White 
 
Beige 
 
Brown 
Origin MSC-derived white precursors 
MSC-derived beige 
precursors (Ebf2+, 
Pgdfra+) 
dermomyotomal (Myf5+) 
Location 
human: subcutaneous, 
visceral 
mice: inguinal, gonadal, 
mesenteric 
human: subcutaneous, 
supraclavicular 
mice: interspersed with 
WAT (inguinal > gonadal) 
human: cervical, 
supraclavicular, axillary, 
paravertebral 
mice: interscapular, 
perirenal 
Function 
Energy storage (TAGs), 
endocrine signalling, 
immune response 
Adaptive Thermogenesis Energy dissipation, 
endocrine signalling (?) 
Morphology Unilocular LD, few 
mitochondria 
Multilocular LDs, few 
mitochondria (increase 
upon stimulation) 
Multilocular LDs, 
abundant mitochondria, 
highly vascularized/ 
innervated 
UCP1 undetectable/low induced after stimulation high 
Activation Food intake, thiazolidinediones 
Cold, ȕ3-AR stimulation, 
PPARȖ agonists, thyroid 
hormones, 
catecholamines 
Cold, ȕ3-AR stimulation, 
PPARȖ agonists, thyroid 
hormones 
Lipid metabolism 
15 
 
However, they do not originate from Myf5 positive progenitors [69]. Equivalently to white 
precursors, beige precursors originate from mesodermal stem cells [51].  
In contrast to brown adipocytes, which are separated from WAT by a layer of connective 
tissue, in cases where the depots are in close proximity, beige adipocytes are interspersed 
with white adipocytes [70], [71]. All three types of adipocytes display unique genetic profiles 
[51], [67]. Beige adipocytes can be found in WAT depots upon cold-stimulation, long-term 
treatment with PPARȖ (e.g., rosiglitazone) or ȕ3-AR agonist (e.g., CL-316,243), or 
upregulation of intracellular cyclic AMP [3], [72], [73]. The features of the three adipocytes 
types are compared in Figure 2 and Table 1. Chronic stimulation to recruit beige adipocytes 
is often referred to as ‘browning’ of WAT (Figure 6), while they also increase BAT activity 
at the same time. There is an ongoing speculation if this browning response only triggers the 
differentiation of beige precursors in WAT or if it is possible for white precursors or even 
mature white adipocytes to transdifferentiate into beige adipocytes [51], [68]. Two 
observations speak for transdifferentiation: the DNA content or adipocyte number does not 
change during ‘browning’ [74] and beige adipocytes are derived from non-dividing cells [64], 
[72], [75]. From genetic marker studies, it has been suggested that only interscapular BAT 
depots in human infants express classic brown genotypes [70] while supraclavicular BAT 
depots in human infants and adults are actually more comparable to rodent beige adipocytes 
[3], [51], [70], [76]. These beige-like properties are in line with studies showing the 
possibility of recruitment, as typically seen for beige cells, of human adult BAT to previously 
BAT-negative patients [77]–[79].  
 
Lipid metabolism 
Clearly, lipids play a major role in all three types of adipocytes. Moreover, in organisms 
without dedicated AT, e.g., Caenorhabditis elegans, Drosophila melanogaster, and 
Saccharomyces cerevisiae, lipids still play a large role in chemical energy storage [80]–[82]. 
In fact, virtually all eukaryotic cells have the ability to form LDs, in varying numbers and 
sizes, containing neutral, i.e., uncharged, lipids, especially upon exposure to high levels of 
nutritional NEFAs. An average non-obese person stores around 500 000 kJ of chemical 
energy in adipocyte TAGs, enough for ~30 marathons [83]. This is 200-fold more energy 
than is contained in the liver- and skeletal muscle-stored glycogen, the multibranched 
polysaccharide that serves as main fuel for muscles [83]. When lipids are needed for energy, 
they are packed into lipoprotein and released into the plasma. Lipoprotein particles are built 
from a single phospholipid layer, with embedded apolipoproteins, and a TAG/cholesterol 
core and can vary in size and density. Due to their analogous architectures, lipoprotein 
particles can be viewed as miniature LDs [83].  
In contrast to earlier understanding, LDs are not only inert lipid storages but rather contribute 
to diverse cellular functions, including signaling, temporary protein storage, and protein 
degradation [84]–[86]. 
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Figure 6. Browning/Whitening of WAT. (A) The number of beige adipocytes in WAT can be 
increased with cold temperature or ȕ3 -AR stimulation (browning), while the number decreases with 
thermoneutrality or high-fat diet/obesity (whitening). Both white and beige adipocytes are derived from 
MSCs. There has also been speculation about transdifferentiation of adult white adipocytes. Adapted 
from [23]. (B) left: iWAT from 9 week old C57/BL6 mice, right: after 10 day injection with ȕ3-AR 
agonist (CL316,243,1 μg/g). Lipids are shown in magenta (CARS, 2845 cm-1), mitochondria in green 
(MPEF, Rho123). Scale bar: 40 μm. 
Despite being a way to deal with toxicity of NEFAs for most cells [33], the occurrence of 
LDs has also proven detrimental to certain cell types, e.g., pancreatic ȕ-cells, where excess 
lipid accumulation interferes with insulin secretion and can lead to apoptosis [87], [88]. In 
addition to the presence of LDs as disease indicators, the TAG chemical composition, i.e., the 
length of the chains and the number of C=C bonds, can be of importance. For example, the 
chain length of NEFAs in blood correlates with stimulated insulin secretion [89], while 
saturation levels of lipids found in skeletal muscle cells are linked to insulin resistance [90]. It 
has also been shown that there are hepatic inter- and intra-cellular differences in LD 
composition as possible mechanism to reduce lipotoxicity [91], [92]. LDs can grow or shrink 
within hours upon changes in the nutrient source [93]. One of example where LDs change 
dramatically is adipogenic differentiation of stem cells.  
In mammalian adipocytes, LDs consist mainly of TAGs and to lesser extent of sterol esters 
and diacylglycerols (DAG) [94]. LD size can vary by three orders of magnitude from 100 nm 
to 100 μm. The hydrophobic droplets are covered with an emulsifying monolayer of 
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phospholipids that contain a specific subset of proteins (Figure 7), such as the perilipin 
protein family [95], [96]. Some of the proteins on the LD surface are also found in the 
endoplasmic reticulum (ER) membrane, suggesting that LD biogenesis could have its origins 
there [94]. TAGs for storage in LDs can be produced from two different pathways: (i) de 
novo lipogenesis of NEFAs from products of glycolysis and esterification, or (ii) uptake and 
direct esterification of NEFAs from plasma. Although there are typically many enzymes 
involved in these pathways, the following paragraphs will focus on important reporter 
enzymes that are relevant for the work in Paper V.  
De novo lipogenesis 
WAT de novo FA lipogenesis can account for up to 40% of whole-body lipogenesis in 
humans [97]. Besides that, liver and the mammary glands (during lactation) are the main sites 
for FA synthesis, and often liver is the key contributor [98], [99]. In AT, this pathway is only 
active, if carbohydrate intake exceeds energy demand, and has been estimated to contribute to 
approximately 10% of AT TAGs [100]. Glucose, the fuel for de novo lipogenesis can either 
be supplied from carbohydrate sources in the diet or generated de novo in gluconeogenesis. 
The latter process occurs mainly in the liver [101] and Pck1 (cytosolic phosphoenolpyruvate 
carboxykinase) is the main regulator [102]. One of the first steps in de novo lipogenesis is 
carried out by the multi-enzyme complex fatty acid synthase (FASN), which is indirectly 
controlled by insulin [103]. Desaturases (SCD) and elongases (ELOVL) are employed to 
adjust number of double bonds and chain length of FAs to cellular needs. The main FAs 
found in mammalian LDs are C16 and C18, both saturated and mono-unsaturated [94]. 
SREBF1c (sterol regulatory element binding factor) is a transcription factor that is linked 
with activation of Fasn and Scd1 [104]. Another gene involved is Agapt2 (1-acylglycerol-3-
phosphate-O-acyltransferase), which generates precursors, phosphatidic acid, for both TAGs 
and phospholipids and is crucial for adipocyte differentiation [105]. 
FA esterification 
Most of the TAGs in WAT are produced from circulating TAGs and FAs, packed with 
lipoproteins, derived from nutrition or de novo lipogenesis in liver. Lipids absorbed via the 
small intestine are packed in chylomicrons and lipids produced in the liver travel in the blood 
packed as very low density lipoprotein (VLDL). They are freed from their protein packing in 
the extracellular space by lipoprotein lipase (LPL), secreted from adipocytes. Exactly how the 
FAs gets into the adipocytes is not fully understood [106].  
Inside the cell, one of the key molecules required for the esterification of FAs is glycerol-3-
phosphate (G3P), which can be formed from: (i) glucose via the glycolytic pathway, (ii) 
glycerol (employing glycerol kinase), and (iii) other precursors [25]. In WAT 
glyceroneogenesis (pathway iii) is preferred [107], [108], while BAT depends on glycerol 
kinase [109]. The main enzymes for TAG synthesis in mammalian cells are acyl-coenzyme A 
(aycl-CoA):diacylglycerol acyltransferase (DGAT1 & DGAT2); they add a third acyl chain 
to DAG molecules. 
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Figure 7. Lipid droplet. The LD is filled with neutral lipids (TAGs and cholesterol) and surrounded by 
a phospholipid monolayer with cholesterol and different proteins embedded. Reprinted with 
permission from [110].  
 
 
Figure 8. Lipolysis in WAT. Small LDs (magenta, CARS, 2845 cm-1) on the surface of white 
adipocytes (circle top row) are surrounded by active mitochondria (green, MPEF, Rho123, circle 
bottom row). White adipocytes are embedded by fibrillar collagen (cyan, SHG) and elastin (green, 
MPEF, arrow head). Scale bars: 40 and 5 μm.  
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DGAT1 localizes in the ER, while DGAT2 localizes with the LD and mitochondria [111], 
[112]. The expression ratio between the two depends on the tissue, with typically lower levels 
of Dgat1 than Dgat2 in liver and AT [113], [114]. Only DGAT2 is essential for survival [37]. 
The substrates for the DGATs are generated from G3P and FAs. GPD1 (glycerol-3-phosphate 
dehydrogenase) catalyzes the production of G3P, and GPAM (glycerol-3-phosphate 
acyltransferase) adds the first acyl chain [115]. 
Lipolysis and FA utilization 
When lipids are needed for energy or membrane lipid synthesis, FAs are mobilized from 
TAGs via lipolysis governed by adipose triacylglyceride lipase (ATGL) and hormone-
sensitive lipase (HSL) [116]. The hydrolyzed lipids in AT are then either re-esterified to 
TAGs, used for mitochondrial long chain ȕ-oxidation, which is crucial for BAT 
thermogenesis, or shuttled to other tissues for consumption there. In white adipocytes it can 
also be noted that lipolysis seems to occur in proximity to mitochondria (Figure 8). A 
complex trafficking system is set up inside cells to ensure maximum oxidative metabolism 
and avoid FA toxicity [117]. FAs can induce UCP1-dependent thermogenesis both in WAT 
[118], [119] and BAT [120]–[122] with carnitine palmitoyltransferase 1 (CPT1) as rate-
limiting enzyme. The re-esterification rate after lipolysis increases upon fasting reaching 
almost 60% in 60 h starved humans [123]. It is commonly assumed that this re-esterification, 
which ‘costs’ ~ 3% of the energy content of one TAG molecule, is due to insufficient 
sensitivity in the regulation of lipolysis [107]. TAG has an energy density of 30 kJ/g while 
glycogen has 17 kJ/g as free molecule and 4 kJ/g in the hydrated form [124]. Since there is a 
constant release of NEFAs from the LDs in WAT their half-life is estimated at 250 days. 
However, this is a long time compared to oxidative tissues like muscle or liver, inside which 
the LD half-life is 24 and 100 h, respectively [124]. 
Supply of NEFAs to other tissues 
The majority of lipids that are released from WAT or liver are supplied to other tissues in a 
controlled way. The flow of NEFAs between organs depends on the nutritional state. After a 
meal (postprandial), due to increased plasma insulin concentrations, more NEFAs are stored 
as TAGs in WAT, compared to the fasting state. LPL, the enzyme that hydrolyses TAGs in 
lipoproteins, to allow NEFAs uptake into adipocytes, is upregulated [59]. At the same time 
lipolysis is suppressed by insulin, along with VLDL-TAG release from the liver. This means 
that while there is a high amount of circulating lipids (from food), FAs are not produced by 
de novo lipogenesis. During fasting, the liver and AT release NEFAs to support metabolism 
in other cells, e.g., skeletal muscle and heart [124]. This differential response of stopping 
lipolysis postprandial and subsequent resumption is important to keep plasma FA levels 
within a healthy range [125]. All in all, WAT in symbiosis with liver and muscles acts as 
buffer organ for lipid flux, switching between lipid storage and release, similar to the role of 
liver in buffering glucose levels. Non-esterified FAs and chylomicron-TAGs (lipoprotein 
packed TAGs from food) have half-lives of only 3 and 5 minutes in plasma before they are 
taken up by cells, while non-chylomicron-TAGs, e.g., VLDL-TAGs stay in the plasma for 
approximately 120 minutes [34].  
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Since BAT relies on FAs to fuel thermogenesis, it might not be surprising that BAT has a role 
in postprandial TAG clearance especially when activated. The majority of TAGs in BAT is 
extracted from circulation lipoproteins, which depends on LPL activity. In this process, the 
signal for production/release of LPL is norephedrine [126], [127]. Norepinephrine release 
leads to an accelerated plasma TAG clearance already after short-term cold exposure, 4 – 24 
h, in mice [53]. In unstimulated BAT, TAGs originate mainly from de novo lipogenesis using 
glucose [42].  
 
Pathological changes in obesity 
Tissue morphology 
The hallmark of obesity is the excess volume of AT, which is also the single identifying 
marker visible from the outside of the patient. The clinical definition of obesity is set to a 
BF% where the excess lipid storage causes health problems leading to increased mortality. It 
has been suggested that the definition should be changed to include the metabolic dysfunction 
that diminishes the ability of AT to protect other tissues from lipotoxicity [128].  
Obesity usually develops slowly due to a long term positive energy balance causing the body 
to store this excess energy in the form of TAGs that slowly fill the capacity of AT. There are 
two ways AT attempts to handle the increased amount of circulating lipids under constant 
overfeeding: (i) enlargement of existing adipocytes, hypertrophy, or (ii) increase of adipocyte 
numbers, hyperplasia. Both adaptations occur in gWAT, while in iWAT only hypertrophy 
has been found [129]. However, if the AT cannot store all the lipids and the circulating 
NEFAs reach a concentration which is toxic to most cells [33], lipid depots are eventually 
formed in other tissues, e.g., skeletal muscle and liver [110].  
In contrast, BAT mass decreases during long-term positive energy balance and thus during 
obesity [44]. Additionally, in obesity, through the control of TGF-ȕ signaling, beige 
adipocyte differentiation is suppressed, hence leading to fewer beige adipocytes in WAT 
[51]. It is not fully understood if diet leads to changes in number of beige and brown 
adipocytes directly and/or indirectly via organs involved in stimulation of non-shivering 
thermogenesis, e.g., liver (FGF21 signaling), skeletal muscle (Irisin signaling), hypothalamus 
(norephedrine) [23].  
It has also been found that not all AT depots behave equally under prolonged surplus of 
energy. Expansion of visceral AT (deep in the abdomen and around the organs) has been 
especially linked to many of the adverse health effects obese patients face, such as 
hypertension, dyslipidemia, and T2D [28], [32]. Subcutaneous WAT expansion has not been 
similarly linked to adverse health effect, due to its ability to act as a buffer for lipid influx, 
thus preventing ectopic built-up of lipids [27] and the secretion of more beneficial adipokines 
[130]. For example, non-obese patients with high visceral-to-subcutaneous fat ratio are more 
likely to be insulin resistant [131]. In both WAT depots, smaller adipocytes are more insulin 
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sensitive than larger ones [132], and the presence of larger adipocytes in subcutaneous WAT 
have been linked to an increased risk for T2D [133]. To summarize, it is fair to say that 
increased subcutaneous AT is rather “metabolically healthy” whereas excess visceral AT is 
more “metabolically unhealthy”.  
AT inflammation and insulin resistance 
With an increase in adiposity, somehow the endocrine function of adipocytes gets 
dysregulated, which is key in obesity-related insulin resistance. FA plasma levels are elevated 
in obese patients, in parallel to the increase in fat mass. These FAs, together with several 
other metabolites, have been thought to impact intracellular kinases, which in term can impair 
insulin signaling [134], [135]. Some of the factors secreted from AT, like monocyte 
chemoattractant protein-1 (MCP1), are linked to the increased macrophage infiltration found 
in obese mice [136] and humans [137]. The presence of macrophages increases from 5-10% 
to 50% of all cells in AT during obesity [137]. This increase in macrophage numbers in AT 
has been linked to insulin resistance in skeletal muscle, via macrophage secreted cytokines 
that trigger increased lipolysis and decreased TAG synthesis in adipocytes [138]. However, at 
the same time, it has been shown that AT inflammation is crucial for tissue expansion, which 
if disrupted leads to increased ectopic lipid depositions [139]. Ectopic lipid depositions 
become especially visible in liver, which under normal conditions contains 1-10% lipids by 
weight, but can increase significantly and lead to non-alcoholic fatty liver disease [124]. Thus 
there is clearly a balance between “normal” AT expansion and metabolic abnormalities. 
 
Adipogenic differentiation of stem cells as a model for obesity 
research 
In order to study adipocyte function, in vitro models have been established [140]. Besides 
stable cell lines, one of the promising approaches is the differentiation of adipose-derived 
stem cells (ADSC) or MSC into cells of adipocyte lineage. For both stem cell types, a beige 
or beige/brown differentiation protocol, in additional to a white adipocyte commitment, has 
been developed [140], [141]. The following sections will focus on white adipogenesis which 
is relevant for Paper II.  
Stem cell niches in AT 
AT contains ADSC to be able to regenerate and regulate its cell number. These stem cells are 
part of the stromal population in AT together with microvascular endothelial cells and 
smooth muscle cells. The stem cell fate is not only regulated by intrinsic factors, but also by 
the interaction with its environment. Every cell in the body is in contact with extra cellular 
matrix (ECM) proteins at some point (Figure 9), which conveys a number physical and 
biochemical cues that can alter differentiation programs. Cells react to ECM mechanical cues 
in a complicated process known as mechanotransduction [142]. This mechanosensitivity of 
adipocytes has been observed in vivo and in vitro [143].  
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Figure 9. ECM in gWAT of mice. Adult and precursor cells are in close contact with the ECM in 
gWAT. Lipids (magenta, CARS, 2845 cm-1), fibrillar collagen (cyan, SHG), elastin (green ‘strings’, 
MPEF). Scale bars: 40, 20, and 5 μm.  
In connective tissue, like WAT or cartilage, cells are completely surrounded by the ECM, to 
which they adhere via different surface proteins, which can also modulate cell fate [130].  
During the development of AT in the embryo it is presumed that AT starts out as a loose 
connective tissue with sparse population of mesenchymal cells. Those cells are further 
expanded and blood vessels are formed. Subsequently, the cells start to accumulate small 
lipid depots, which later transform into the large LD in mature adipocytes. This final step of 
differentiation is accomplished after birth [144]. Stem cells in formed tissues reside in 
specialized niches and it is believed that mechanical cues in those niches can help to decide 
over a proliferation or differentiation pathway [145]. Human ADSC localize into a 
perivascular niche during early AT development as well as in mature tissue [144]. AT is 
dynamic and contains a vast mixture of mature adipocytes, precursor cells, extracellular 
vesicles, immune cells, fibroblasts and extracellular matrix. Adipocyte precursor cells, like 
mesenchymal cells, can remodel their own ECM during their development; they change both 
structure and composition of the ECM during this process. It has been found in vitro, that 
collagen IV and laminin expression is upregulated, while fibronectin expression decreases 
during differentiation [146]. This suggests that the differentiation matrix for hADSC is more 
laminar than fibrillar, which accommodates for cell size expansion. Additionally, many 
degrading enzymes are active during the differentiation process facilitating tissue remodeling. 
During obesity, AT is in a state of chronic tissue inflammation, which is also characterized by 
increased fibrosis of the tissue. Consequently, more fibrous collagen is found in AT of obese 
patients, which makes it stiffer [147]. Macrophages, which are recruited during inflammation, 
contributes further to the ECM production [144] and are key-initiators of the matrix 
remodeling during obesity [148].  
Adipocyte differentiation in vivo  
Adipocytes develop, in vivo, from mesenchymal stem cells in the AT. The vast majority of 
adipocytes are developed during late gestation. In the adult tissue, on the other hand, 
differentiation events occur in order to keep a constant cell number [149]. Stem cells are 
usually kept in a state, where pro- and anti-adipogenetic Wnt signaling pathways keep each 
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other stalled, resulting in maintenance of stem cell features [150]. A signal from outside the 
stem cell is needed to disrupt this balance and initiate differentiation [150]. Gene expression 
during differentiation is tightly controlled and first initiates a determination phase, where the 
stem cell commits towards adipocyte linage and can no longer differentiate to any other cell 
type (Figure 10). At this point, the cells reach growth arrest and withdraw from the cell 
cycle, in order to allow adipose conversion. In the second phase, the termination, lipid 
transport and synthesis, and insulin sensitivity are established. Additionally, secretion of 
adipocyte-specific proteins is commenced. This signaling cascade can be started by intrinsic 
factors, cell-cell contact, cell-ECM contact, or cell shape [150]. Two important genes in this 
signaling cascade are the nuclear peroxisome proliferator-activator receptor Ȗ (PPARȖ) and 
CCAAT-enhancer-binding proteins (C/EBPs). PPARȖ is needed to initiate and maintain 
adipocyte differentiation. Several C/EBPs participate during adipogenesis and these proteins 
cannot function efficiently without PPARȖ [149]. However, some of the steps in this 
signaling pathway remain obscure. Investigating signaling pathways controlling in vivo 
differentiation is complex. Murine knockout models are used to understand the role of 
individual genes in development. 
Yet, knockout or upregulation of relevant genes might lead to high frequencies of life 
impairing diseases and initiation of compensatory mechanisms. Thus, many conclusions 
about in vivo differentiation are drawn from in vitro studies, with cell lines or stem cells. A 
problem with such systems is that all stem cell linages do not behave in the same way, 
leading to difficulties in understanding and relating gene expressions. Sometimes, in vivo and 
in vitro findings even contradict each other, for example, sterol regulatory element binding 
factor 1c (SREBF1c) as a transcription factor [149]. In vitro SREBF1c seems to be crucial for 
lipid PPARȖ expression [151], while in vivo, mice lacking SREBF1c display normal fat pads 
[152]. 
There are more than a hundred reported transcription factors expressed in adipocytes, of 
which many affect differentiation. Not all factors bind to DNA, protein-protein interactions 
can also affect gene expression by forming for example co-activator or co-repressor 
complexes. 
 
Figure 10. In vivo adipogenesis of ADSC. The differentiation of ADSC occurs in stages. First, the 
multipotent stem cell, which can give rise to osteoblasts, chondroblasts, adipocytes, commits towards 
a linage. In this case the commitment is towards a white preadipocyte linage. From there 
adipogenesis occurs with enhancing (↑) and inhibiting (┬) factors. After initial differentiation the 
adipocyte matures and the unilocular lipid droplet forms.  
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Many evolutionary highly conserved pathways are important for adipocyte differentiation. 
Activity in a Wnt signaling pathway and a hedgehog pathway seem to inhibit adipocyte 
differentiation in vitro, while in vivo, involvement of the same pathways is likely to increase 
differentiation [149], [150]. Although many involved factors in the adipocyte differentiation 
are identified, both in vivo and in vitro, it has been difficult to design an in vitro 
differentiation protocol, which offers all stimuli present in the in vivo AT. On top of that, 
some signaling molecules which have been identified in mature adipocytes, inhibit 
differentiation if added in the determination phase during in vitro differentiation. These are 
some of the difficulties of replicating the perfect timing of the natural signaling cascade in an 
in vitro setup. 
ADSC differentiation in vitro 
The stromal-vascular fraction in AT can enzymatically be isolated from the tissue and 
separated from the mature adipocytes via centrifugation. Subsequent passaging of the cells 
leads to a more homogenous cell population, which is then termed ADSC. ADSC have the 
ability to extensively proliferate and commit to multiple lineages derived from mesenchymal 
cells, towards adipocytes, osteoblasts, or chondrocytes. They are therefore part of a superior 
population (MSCs) [31]. ADSC and bone-marrow MSC, among others, can be used to obtain 
adipocytes in in vitro cultures. However, so far no fully functional adipocyte-phenotype could 
be achieved using in vitro differentiation.  
During the differentiation of ADSC several compounds and hormones are added to the 
culture medium. The four main ones are pioglitazone, dexamethasone, 3-isobutyl-1-
methylxanthine (IBMX), and insulin. Some of these compounds can be replaced with 
chemically similar molecules, which will induce the same effects. Pioglitazone is originally 
an antidiabetic drug, which enhances insulin sensitivity. Drugs in this group are activators of 
PPARȖ, thus increasing the transcription of insulin-responsive genes [153]. Dexamethasone 
is a glucocorticoid agonist, typically used to maintain organ transplants and to manage 
chronic inflammations. Glucocorticoid expression upregulates also transcription of a class of 
PPARȖ and C/EBP [154]. IBMX raises intracellular cAMP levels by inhibition of 
phosphodiesterase [155]. Insulin is important for the differentiation of adipocytes and there 
are at least four points of interference in the gene expression cascade [149].  
Although there are many similarities between in vitro differentiated adipocytes and freshly 
isolated mature adipocytes, e.g., lipolysis, insulin stimulated glucose uptake, secretion of 
adipokines [156]–[158]; the in vitro adipocytes contain multilocular LDs (Figure 11), show 
different levels of maximal lipolysis [159] and of secretion of VEGF and bFGF [160].  
In order to improve in vitro differentiation, the need of mechanic cues like response to cell 
stretching, compression, and shear stress from fluid flow, has been explored. This opens up 
the possibility using materials that can support and/or enhance adipocyte differentiation in 
vitro. Such materials can for instance be designed to mimic AT. Therefore, it is desired that 
they are soft, but also stable and support stretching of cells as well as allowing the cells to 
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round up when they have differentiated further. It has even been shown that micro- and nano-
patterns can influence cell fate [161].  
 
Figure 11. In vitro adipogenesis of progenitor cells. hADSC accumulate LDs (magenta, CARS, 
2845 cm-1) over the course of 14 days differentiation in vitro on cell culture treated plastic. The LDs in 
the cells remain multilocular. Intrinsic cellular fluorescence (green, MPEF) shows the cytosol and 
outlines of the cells. Nuclei are seen as an absence of signal (circle). 3T3-L1, a mouse fibroblast cell 
line, can also be differentiated into adipocytes (bottom right). Scale bars: 25, 10, and 50 μm.  
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An overview of methods 
Standard histological images of LD-containing tissues are known to show empty shells where 
the droplets used to be. The lipids inside these LDs are lost during embedding in paraffin and 
dehydration. Small LDs (< 2 μm) are challenging to identify from sections prepared in this 
way. Only with advances in optical and electron microscopy has the presence of LDs in 
nearly all cell types been confirmed. Still, there are short-comings to current methods leaving 
many fundamental questions in LD biology open [162]. 
There are two principal areas of LD physiology that need further research and development: 
(i) imaging LD morphology, dynamics, and interaction with other molecules/organelles, and 
(ii) revealing the chemistry of the molecules that make up LDs. These two areas require 
somewhat different experimental approaches, and this chapter will focus on the methods 
developed and employed that are part of this PhD thesis.  
 
Toolbox I: Microscopy for LDs and their dynamics 
When considering cell dynamics, different time scales can be of interest. Cells migrate over 
hours, organelles move within minutes, and molecular interactions form within seconds or 
less, while adaptions of in vivo tissue to external influences or differentiation of stem cells 
can take days to months. Additionally, LDs can range in size from several nm to 100 μm, 
similarly to lipoproteins. Ohsaki, Suzuki, and Fujimoto speculate that even the density and 
protein content in LDs varies analogous to that of lipoproteins [162]. This large heterogeneity 
among LDs is not likely to be captured by a single technique. Three main techniques can be 
employed to visualize LDs in vitro: electron, fluorescence, and nonlinear microscopy, which 
are briefly introduced and compared below.  
LDs, but not their phospholipid membrane, are visible using osmium tetroxide as stain for 
transmission electron microscopy (TEM). Due to limits in contrast, LDs below 50 nm 
diameter have proved challenging using this technique [163]. Yet, a more integral challenge 
is the sample preparation. Aldehydes, which are routinely used in TEM sample preparation, 
do not react with lipids; osmium tetroxide and uranyl acetate bind lipids albeit not uniformly 
[162]. Both lipid-binding cross linkers react mainly with C=C bonds in the acyl chains, thus 
the image contrast can be modulated by lipid saturation level in an unknown way. Cryo-, 
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freeze fracture, and deep-etch EM allow direct observation of LDs without crosslinking. 
These techniques can be used to visualize the phospholipid monolayer on isolated LDs [164], 
gold-nanoparticle labeled proteins on the surface of (and even inside) LDs from fractured 
cells [164], [165], and LDs in, e.g., macrophages [164]. TEM offers the highest theoretical 
resolution of the techniques compared with ~ 50 pm [166]. Cryo-EM has lower resolution at 
~ 300 pm, withal gaining the feasibility to map 3D structures [167]. Nevertheless, the 
mapping of crowed cellular spaces is challenging, it is not possible to follow biological 
processes in real-time, and no quantitative differentiation between lipid chemical species can 
be made using EM.  
For that purpose, fluorescence microscopy is better suited. Especially with recent advances in 
super-resolution microscopy allowing the visualization of biological molecules in situ with ~ 
20 nm resolution [168]. Hell et al. summarize advances in super-resolution techniques as well 
as challenges faced [169]. One of the major trends in this field is the move towards live-cell, 
3D imaging [168]. With the development of new dyes combined with structured illumination 
microscopy, the possibilities to achieve sufficient resolution in 3D are within reach [168]. 
There is now a multitude of dyes available for imaging lipids with conventional confocal 
laser scanning microscopy (CLSM), with ~ 180 nm resolution [170]. The main drawback 
here is that these dyes might interfere with LD motility [171], label LDs unevenly due to 
changes in composition [92], or get excreted over time by intracellular transporters [172].  
Nonlinear microscopy, a collection of several techniques allows, in addition to fluorescence, 
the possibility to visualize lipids and other biological molecules without external labeling. 
The resolution here is limited at ~ 300 nm [173], [174]. As the focus of this thesis is on 
nonlinear microscopic lipid visualization, I will primarily describe coherent Raman scattering 
(CRS) and briefly third harmonic generation (THG), which have been extensively used to 
visualize lipids in cells, tissues, and even organisms. These two techniques can be readily 
combined with other nonlinear microscopy techniques such as second harmonic generation 
(SHG), visualizing fibrillar collagen or dendrites in nerve cells, or multi-photon excited 
fluorescence (MPEF).  
Nonlinear microscopy 
Basic principles 
The theoretical basis for non-linear microscopy was established in 1931 by Maria Göppert-
Mayer, who mathematically showed the possibility for two-photon adsorption and its 
quadratic dependency on the intensity of light [175] (English translation: [176]). In 1977, 
with the development of more powerful light sources, this process could be utilized for image 
generation [177]. Along with the construction of pulsed lasers with high peak-powers, more 
nonlinear processes could be explored and employed.  
Nonlinear optics as a discipline is set apart from linear optics, the class of light-matter 
interactions behind everyday effects like rainbows, cameras, or telescopes that is also the 
basis of epifluorescence microscopy and CLSM. These interactions occur with natural, low 
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light intensities and physical parameters describing them depend linearly on the incident light 
electric field amplitude (and therefore intensity). A much higher light intensity is needed to 
trigger light-matter interactions classified as nonlinear. In such processes, the induced 
polarization in a material with caused by the incident electric field (light) is no longer linearly 
dependent on the field amplitude.  
The theory behind nonlinear optics in general, and specifically coherent Raman scattering has 
been described in detail in textbooks [178], [179]. Briefly, the induced macroscopic 
polarization 𝑃ሺݐሻ of the electric dipoles in a material depends on the strength of the applied 
optical field 𝐸ሺݐሻ. For weak electric fields (compared to the fields binding electrons to the 
nucleus), this relation can be formulated in a linear dependence as: 
 𝑃ሺݐሻ = 𝜀଴  𝜒ሺଵሻ  𝐸ሺݐሻ eq. 1 
where 𝜀଴ is the electric permittivity in vacuum and 𝜒ሺଵሻ the linear susceptibility of the 
material. For stronger fields, 𝑃ሺݐሻ can be expanded as a power series:  
 𝑃ሺݐሻ =  𝜀଴  [ 𝜒ሺଵሻ  𝐸ሺݐሻ +  𝜒ሺଶሻ  𝐸ଶሺݐሻ +  𝜒ሺଷሻ  𝐸ଷሺݐሻ + ⋯ ] eq. 2 
 =  𝑃ሺଵሻሺݐሻ +  𝑃ሺଶሻሺݐሻ +  𝑃ሺଷሻሺݐሻ + ⋯  
where 𝜒ሺ௡ሻ is the nth order susceptibility. 𝑃ሺ௡ሻ is the nth order polarization. The physical 
processes occurring as result of the second-order polarization differ from the third-order 
polarization. There is a multitude of processes that can occur in the nonlinear regime. The 
following sections focus on processes originating due to 𝑃ሺଶሻ or 𝑃ሺଷሻ as they commonly occur 
in biological samples. Due to the applied nature of this thesis the mathematics behind 
solutions for the prediction of 𝑃ሺଶሻ or 𝑃ሺଷሻ are omitted. 
Coherent Raman scattering (CRS) 
Raman scattering describes a light-matter interaction, where the response of the interaction 
between incident light and matter contains information about molecular oscillations of 
chemically bound nuclei. Typically the main portion of the incident light with the frequency 𝜔ଵ undergoes Rayleigh (elastic) scattering, meaning the same light frequency (energy) is 
scattered (Figure 12A, B). However, a relatively small fraction of scattering results in light 
with discrete frequencies above or below that of the incident light. This spontaneous Raman 
(inelastic) scattering is called Stokes Raman or anti-Stokes Raman, depending on if the 
emitted light frequency is lower (𝜔ଵ − 𝜔𝜐ሻ or higher (𝜔ଵ + 𝜔𝜐ሻ  than the incident light 
frequency 𝜔ଵ (Figure 12A, B). 𝜔𝜐 denotes the nuclear resonance frequency. Although it is 
the electrons that are set in motion by the light field, this motion is perturbed by the presence 
of the nucleus position and hence the electronic polarizability depends on 𝜔𝜐. The change in 
polarizability depends on the symmetry of the nuclear modes, and this forms the basis for 
selection rules in Raman spectroscopy. A mode is only Raman active if the change in 
polarizability with nuclear motion is not zero [180].  
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For spontaneous scattering, each molecule carries out an independent spontaneous oscillation, 
which radiates a field that is not correlated in phase with any other molecule; there is no 
synchronization of the process. In practice, Raman scattering efficiency can be formulated 
with a cross section σ, analogous to (but different in physical origin from) the Lambert-Beer 
law for absorption. The total Stokes contribution of the scattered Raman-shifted light can be 
formulated as:  
 𝐼ሺ𝜔௦ሻ = ܰ 𝑧 𝜎ሺ𝜔௦ሻ 𝐼଴ eq. 3 
where ܰ is the molecular density, 𝑧 the length of the sample, and  𝐼଴ the intensity of the 
incident beam. Spontaneous Raman scattering is a weak process that is linear in molecular 
density and intensity of the incident beam. The anti-Stokes components are typically orders 
of magnitude lower in intensity compared to the Stokes components, since anti-Stokes 
transitions occur from excited vibrational states which are not as frequently populated at 
thermal equilibrium.  
The possibility of Raman transitions can be increased in a nonlinear way when a combination 
of intense laser sources is used with appropriately chosen energies. The resulting process is 
denoted as coherent Raman scattering (CRS) [181]. CRS is a third-order nonlinear process 
where a pump (𝜔௣) and Stokes (𝜔௦) stimulate a specific transition. This process is enhanced 
if 𝜔௣ − 𝜔௦  is in resonance with a vibrational (or rotational) transition of the probed 
molecule. In this case, one type of signal called stimulated Raman scattering (SRS) can be 
detected as a modulation of the intensities of the incident Stokes and pump beam via the 
coupling of the light fields with molecule. With improvements laser technology, modulation 
of one of the laser fields, and lock-in detection, this process can be employed for real-time 
label-free biomedical imaging [182], [183].  
The stimulated Raman process also occurs concurrently with so-called coherent anti-Stokes 
Raman scattering (CARS). In this process, the molecular coupling induced by the interaction 
of the two light fields (𝜔௣ and  𝜔௦) is probed by scattering a third (probe) light field off the 
driven molecular oscillation. The scattered field gains energy from the driven oscillation (at Ω = 𝜔௣ − 𝜔௦) so light at a new frequency is created and can be detected (Figure 12C, D). 
The new frequencies are in principle: Ω +  𝜔௣, Ω +  𝜔௦௧௢𝑘𝑒௦, and Ω +  𝜔௣௥௢௕𝑒. In CARS as 
implemented in this work and nearly all other examples, the pump and probe light fields are 
the same and the light at frequency Ω + 𝜔௣ is detected. The whole process can be 
summarized as: 
 𝜔𝐶𝐴ோௌ =  𝜔௣ − 𝜔௦ + 𝜔௣௥ = 2 𝜔௣ −  𝜔௦ eq. 4 
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Figure 12. Spontaneous Raman scattering and CARS. (A) Spontaneous scattering results in 
incoherent photons. (B) Jablonski energy diagrams: The scattered photons can either be scattered 
with the same energy (Rayleigh), transfer some of their incident energy to the matter (Stokes Raman), 
or increase their incident energy upon interaction with matter in an excited vibrational state (anti-
Stokes Raman). (C) CARS is coherently driven process, where three incident photons interact 
simultaneously to generate anti-Stokes scattering. (D) The CARS process begins and ends in the 
electronic and vibrational ground state (S0, v=0). S0 electronic ground state, v=0-3 vibrational states, 
dashed lines denote virtual states. (A, C) reprinted with permission from [184]. 
Importantly, in CRS, vibrations, are coherently driven by the beat field at Ω, making all 
molecules vibrate in phase, which is a major reason why these techniques strongly enhance 
the Raman process compared to (spontaneous) linear Raman scattering. By tuning the 
difference between 𝜔௣ − 𝜔௦  (Ω), different molecular vibrations can be driven and measured. 
In order for this process to occur, additional technical conditions must be fulfilled including 
phase matching, i.e., momentum conservation for the four light fields, which would 
necessitate specific angles between the incident and CARS beams. However, in a microscope 
when the incident light fields are focused in the sample through a high numerical aperture 
objective, this condition can be relaxed [174]. CARS is a parametric process, i.e., the energy 
of the matter does not change before and after the interaction. 
CARS was first observed in 1964 [185] and employed for microscopy in 1982 [186]. 
However, with the use of visible light sources the technique was rendered ineffective by two-
photon enhanced background signals. As recently as in 1999, with implementation of tight 
focusing conditions, which relaxes the phase matching, and near IR light, reducing photo 
damage and enhancing sensitivity, CARS microscopy became applicable to perform 3D scans 
on a vast array of different samples [174]. Although this implementation improved CARS 
3  In situ analysis of adipocyte physiology 
34 
 
sensitivity, the method is not background-free due to oscillating electron clouds that can also 
cause radiation at detected CARS frequency yet have nothing to do with molecular 
vibrations. This can be seen by writing the relationship between the intensity of the CARS 
signal and induced polarization:  
 𝐼𝐶𝐴ோௌ  ∝  |𝜒ሺଷሻ|ଶ  eq. 5 ∝  |𝜒ோሺଷሻ + 𝜒𝑁ோሺଷሻ|ଶ ∝  |𝜒ோሺଷሻ|ଶ +  |𝜒𝑁ோሺଷሻ|ଶ + 2 𝜒𝑁ோሺଷሻ   ܴ݁ {𝜒ோሺଷሻ} 
where the third order susceptibility 𝜒ሺଷሻ is a complex sum of resonant (𝜒ோሺଷሻሻ and non-
resonant 𝜒𝑁ோሺଷሻ contributions. The non-resonant term leads not only to a spectrally flat 
background, but also to a crossed term that introduces spectra distortions to CARS spectra 
when compared to spontaneous Raman spectra. This results in a red-shifted peak, compared 
to spontaneous Raman peaks, with a dip at the blue end of the peak [179], [187]. Different 
techniques to reduce the contribution of the non-resonant background (NRB) have been 
demonstrated, e.g., frequency modulation [188], or epi [189], heterodyne [190], or time-
resolved detection [191]. The latter approach has been employed for Paper I-III. With time-
resolved detection, for instantaneous decaying signals like SHG, and fast decaying signals 
like CARS a thresholding window is placed to collect only photons arriving within the 
instrument response time. This reduces the contribution of slower decaying signals like 
MPEF.  
CARS microscopy 
Due to the increased sensitivity of CARS microscopy compared to spontaneous Raman 
microscopy, integration times for image scanning have been drastically reduced and 
facilitated video-rate imaging [192]. Moreover, due to the need of high laser intensities, 
supplied by pulsed laser sources (> 70 MHz) and tight focus, the CARS signal is only 
generated near the focal plane, thus no additional instrumentation is needed to generate 3D 
images. The use of near infra-red laser sources reduces scattering in biological samples and 
allows the imaging of intact tissues with ~ 400 μm penetration depth [187]. Additionally, the 
use of picosecond-pulsed lasers with wavelengths above 800 nm further reduces the photo 
damage [192], [193]. To address single frequencies, picosecond-pulsed laser sources are 
preferred over femtosecond, as often used for other nonlinear techniques, due to a typical 
Raman linewidth of 10-20 cm-1; femtosecond-pulsed lasers have a linewidth of 150 cm-1 for 
100 fs pulses [187].  
The coherent nature of the signal causes the dependence of the far-field radiation pattern on 
more parameters than for incoherent signals, like fluorescence or spontaneous Raman. The 
pattern depends on the nonlinear susceptibility, size and shape of the scatterer, and the local 
sample environment. That can result in differences between forward and epi (or backward)-
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detected CARS signals [194]. While a single dipole would generate the same signal in both 
directions, bulk materials show interferences that typically lead to stronger signal in forward 
direction. However, epi signals can be stronger for very small objects (
𝜆𝑝ଷ ), samples with a 
high number of local changes in refractive index, or if the forward signal is backscattered by 
a turbid sample [187]. These differences can be employed for samples, where a bulk 
substance, like water, conflates the sample response in the forward direction [189] or when 
epi- and forward direction contain complementary information [194]. 
SHG, THG, and MPEF 
In this section, I will describe the other nonlinear microscopy techniques used in my PhD 
work. Second harmonic generation (SHG, Figure 13A) is a second order parametric process, 
which only is non-resonant (does not probe any specific molecular states) but rather 
molecular asymmetry. Being fully non-resonant, this process can be conceptualized through 
so-called virtual states. Virtual states are superpositions of states but not true eigenstates of 
the molecule. Transitions involving virtual states are essentially instantaneous and occur 
synchronously with the excitation pulse. In SHG, the input laser frequency doubled and the 
output signal is fully coherent. SHG can only occur in highly polarizable materials with non-
centrosymmetric molecular organization. Thus, the most common molecules investigated in 
biological samples are collagen, tubulin, and actomyosin complexes [195].  
When three non-resonant fields instead of two are combined, then the process is referred to as 
third harmonic generation (THG, Figure 13B). For a homogenous medium at the focal point, 
the THG waves interfere destructively resulting in net zero signal [178]. If there is an 
interface within the focus, the symmetry along the optical axis is broken and the THG signal 
becomes measurable [196]. This is especially useful for imaging of LDs due to their high 
refractive index compared to the cellular cytosol [197]. 
In contrast to the non-resonant polarization that is the basis for SHG and THG, multi-photon 
excited fluorescence (MPEF, Figure 13C) stems from absorption by and electronic excitation 
of a fluorophore. It resembles one-photon excited fluorescence (OPEF, Figure 13C), except 
that two or three lower energetic photons have to be absorbed at once to bridge the energy 
gap between ground (S0) and excited electronic state (S1). However the selection rules differ 
between OPEF and MPEF. A two-photon absorption is only allowed between states with the 
same parity, while one photon transitions can occur between opposite parity [198]. The 
emission occurs from the lowest vibrational state in S1 for both processes. The band shapes of 
S0 and S1 energy manifolds determine the width and wavelength of the emission spectrum. 
The emission is incoherent (just like OPEF), meaning that we can again linearly add the 
detected intensities unlike for CARS, SHG, and THG [199]. Since this process involves 
electron transitions, the life time of the excited state is of order ns and thus longer than for 
other nonlinear processes (including resonant CARS). Some of the fluorophores developed 
for OPEF can also be excited with near-infrared light and are thus accessible for MPEF. 
Additionally, intrinsic biological molecules in cells and tissues can be multi-photon excited 
[200]. 
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Figure 13. SHG, THG, and O/MPEF. Jablonski energy diagrams: (A) In SHG active, i.e., non-
centrosymmetric, materials, two infra-red photons can combine into one visible photon under 
frequency doubling. (B) In THG active materials, i.e., at interfaces with different refractive indices, 
three infra-red photons can combine into one visible photon under frequency tripling. (C) One photon 
or two photon absorption can lead to electronic excitation from S0 to S1/S2 in fluorophores. After 
internal conversion the emission occurs from the vibrational ground state of the first excited state. S0 
electronic ground state, S1/S2 electronic exited states, v=0-3 vibrational states, dashed lines denote 
virtual states. 
 
Figure 14. rADSC on patterned ELP hydrogels. (A) Dried ELP hydrogels containing cell adhesion 
motifs are either imprinted with aligned (left) or unaligned (right) patterns that vary in spacing 
(wavelength) and height. The 3D structures of the patterns can be visualized with CARS (grey, 2930 
cm-1); however techniques with higher spatial resolution, i.e., AFM are better suited to quantitatively 
extract wavelength and height. (B) rADSC align their cytoskeleton (green, MPEF, Alexa488-Phalloidin 
for F-actin) with the pattern direction (left) or remain randomly oriented (right) on the hydrated gels 
(blue, CARS, 2930 cm-1). Scale bar: 10 and 40 μm. 
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Nonlinear microscopy of adipocyte physiology (Paper I - III) 
CARS microscopy targeting a single vibrational frequency, e.g., 2845 cm-1 for lipids, has 
been extensively employed for different lipid-containing samples: in vitro in lipid vesicles 
[201], lipid bilayers [202], [203], plant cell walls [204], intact skin [205], and hepatocytes 
[206], and in vivo in. c. elegans [207] and mice [192]. Most of these studies have been proof-
of-concept due to the novelty and complexity of CARS microscopy. Thus, the aim for Paper 
I – III was to connect established methods in the fields of tissue engineering and in vivo 
biology with nonlinear microscopy to explore both applications and limitations.  
CARS microscopy for AT engineering (Paper I – II)  
Tissue engineering is an expanding field of in vitro biology, based on the idea that in order to 
generate functional cell models in vitro or to support tissue regeneration in vivo, not only 
chemical stimulation but also mechanical scaffolds are needed. Thus, cells are either placed 
on a surface with stimuli or embedded in a 3D environment. The biological reasons behind 
this and the findings from the Paper I & II will be further discussed in Chapter 4. The 
enhanced complexity of the samples increases the demands for analytical methods.  
In Paper I, ADSC were placed on patterned hydrogels, while in Paper II they were added to 
electrospun polycaprolactone (PCL) fibers that strongly resemble the native ECM in terms of 
size and shape. Hydrogels have been used for a multitude of biomedical applications as 
reviewed by Hoffman [206]. Their great appeal is the high water content, which is important 
for transport of nutrients to cells inside the gels. 
EM calls for either a conductive coating to be applied or drying of the samples. Moreover, the 
samples need to withstand handling in vacuum and at low temperatures for sectioning. Such 
harsh sample preparations can change existing morphologies or introduce new structures into 
the hydrogel. Thus, less invasive methods like atomic force microscopy (AFM) or optical 
techniques are better suited. Label-free methods are preferred since especially in hydrogels 
unspecific accumulations of hydrophobic fluorescence or absorbance dyes with the proteins 
can occur [206].  
In Paper I, micro molding was used to imprint soft hydrogels from recombinant elastin-like 
protein (ELP) with aligned or unaligned patterns with different periodicities and consequently 
the response of rat ADSC to these patterns is explored (Figure 14). Since the hydrogels were 
made of protein, the CH3 vibration at 2930 cm
-1 was used for CARS imaging. In order to test 
the response of stem cells to the surfaces, either the cellular cytoskeleton, here F-actin, or the 
full cytosol were labelled and probed with MPEF concurrently with CARS for lipids and 
CARS for the ELP scaffold. The MPEF signals were readily separated from the CARS 
signals using both dichroic mirrors and filters, and with time-gated signal collection. In 
addition, the near infrared lasers facilitate the excitation of the fluorophores on top of the 50 – 
100 μm thick gels.  
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Figure 15. hADSC on PCL fibers. hADSC were differentiated towards adipocytes on a matrix of 
electrospun PCL fibers for 8 days. The fibers in the matrices were either (A) aligned or (B) random. 
The aligned matrix is approximately 7 μm in thickness consisting of one layer of fibers, while the 
random matrix is 14 μm thick with two layers of fibers as estimated from the average depth of CARS 
(magenta, 2845 cm-1)/MPEF (blue) z-stacks. Distance above the bottom is indicated with numbers. It 
can be seen (from the presence of LDs and cytosolic fluorescence) that in the random matrix few cells 
are at 5-7 μm within the matrix. Most cells are on the surface of the matrix similar to the cells on top of 
the aligned fibers. Cells can be located from the LDs and cytosolic fluorescence. (C) However, the 
PCL matrix itself also shows both CARS and MPEF (zoom in from the white rectangle in B). The 
zoomed in images also demonstrate the difference in background for CARS and MPEF. CARS shows 
NRB over the full image, while for MPEF the majority of the signal comes from the fiber. Scale bars: 
25 and 4 μm. 
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This allowed both the study of cell-material interaction, as well as the response of the 
cytoskeleton inside the cell, showing that aligned wrinkles on the hydrogel can induce an 
alignment of the stem cells after 24h. The insights from this analysis are detailed in Chapter 
4.  
In Paper II, human ADSC were challenged with patterned surfaces. In this work, a 
commercial electrospun PCL matrix was used. The variation of the surfaces is only in the 
alignment of the fibers, not in their diameter or distance between them. Undifferentiated 
ADSC are solely identified via their intrinsic fluorescence. Here, time-gating of the signal is 
of special importance since the fibers display both a CARS signal at 2845 cm-1 and intrinsic 
fluorescence. The contribution of the latter can be reduced if only photons that arrive within 
the instrument response time are considered. Using such time-dependent signal 
discrimination allows separation of signals from cells and fibers. Thereby, we found that the 
cells only minimally sink into the matrix (Figure 15). Thus, most cells are found on top of 
the fibers and not between them. Next, we differentiated the cells towards white adipocytes 
and followed the differentiation via the accumulation of LDs. These contribute a strong 
CARS signal at 2845 cm-1. For classical lipid stains, like Oil-Red-O, the hydrophobic nature 
of the fibers lead to unspecific binding of the dye and the separation of fiber and lipid signals 
during the estimation of the differentiation became more challenging. Due to the ability to 
generate optical sections with CARS and with the help of the intrinsic MPEF the cell area 
could be determined, then the CARS signal of the lipids could be thresholded to estimate the 
diameter of the formed droplets with an adapted voxel analysis as used by Lynn et al. [208]. 
We found that the ADSC differentiated on the aligned nanofiber matrices resembled 
extracted mature adipocytes most in functionality, albeit not in morphology. Qualitative 
investigations of adipogenic differentiation with CARS microscopy have also been employed 
by other groups [171], [209], [210]. 
CARS microscopy to investigate the metabolic state of ex vivo AT (Paper III)  
Whole tissue samples add an additional complexity compared to cells on top of matrices. 
Since CARS microscopy does not need thin samples, the utilization of living ex vivo tissues, 
as applied in Paper III, is possible (Figure 16A, B). Especially for lipid containing tissues, 
this poses the advantage that the lipids remain within the cells and thus allows the estimation 
of cellular morphology as found in vivo. Explanted AT can be cultured for a limited time 
(several hours) before functionality and gene expression change and apoptosis starts [211]. 
Thus, fluorescent staining which relies on active cellular metabolism, e.g., rhodamine123 for 
mitochondrial membrane potential, can be employed for MPEF measurements [212], [213]. 
This can be combined with SHG imaging for fibrillar collagens, as found in the tissue ECM, 
and CARS at 2845 cm-1 for the lipids (Figure 16C).  
Then, the metabolic state of AT can be compared by measuring mitochondrial activity and 
lipid volume per cell (Figure 17). For the purpose of this analysis the central plane of each 
cell is determined, and then the cell area is measured from the MPEF image with increased 
contrast settings.  
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Figure 16. Nonlinear microscopy for ex vivo living tissue. (A) For CLSM tissue samples are 
fixed/snap-frozen, embedded, cut into slices, stained/fixed, and visualized.(B) For nonlinear 
microscopy of AT, staining is done for full ex vivo tissue pieces (if required), the full tissue piece is 
visualized within one hour of extraction and kept at 37°C on the microscope stage. (C) CARS (lipids, 
2845 cm-1, magenta), MPEF (active mitochondria, green, Rho123), and SHG (fibrillar collagen, cyan) 
Scale bar: 30 μm. 
 
Figure 17. Lipids and mitochondria in the three adipocyte shades. (A) White, beige, and brown 
adipocytes in ex vivo mouse tissue .left: iWAT from 9 week old C57/BL6 mice, middle: after 10 day 
injection with ȕ3 AR agonist (CL316,243,1 μg/g), right: interscapular BAT. Lipids are shown in 
magenta (CARS), mitochondria in green (MPEF, Rho123). Scale bar: 40 μm. (B) For each cell a lipid 
content and mitochondria activity can be determined, allowing a ranking of the metabolic state of the 
AT. Brown as the most active tissue, has the lowest lipid content and highest mitochondria activity. N 
= 5 mice. Mean ± SEM. Multiple two-tailed, unpaired Mann-Whitney tests. P values were ranked P > 
0.05 (ns, not significant), P ≤ 0.05 (*), P ≤ 0.01 (**). 
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Afterwards, automated thresholding is performed to determine lipid area and the area covered 
by the brightest, i.e., most active, mitochondria. Both are set into relation with the cell area 
thus giving a percentage quantity. The comparison of percentages instead of absolute 
fluorescence intensity allows the correlation of mitochondrial activity between different 
measurement days, since fluctuations in the fluorescence emission can occur due to minor 
changes in beam shape and/or overlap, or staining efficiency. This is especially useful for 
mixed tissues, like beige AT, where beige adipocytes can be analyzed separated from 
unilocular white adipocytes. However, it is also useful for the comparison of genetic effects 
on BAT and WAT, as shown in Paper III. 
Toolbox II: Visualization of LD chemistry  
While in some cases the morphology is a good indicator for metabolic changes in cells, it can 
be of equal importance to know cellular contents. In the case of LDs, changes in carbon 
saturation and chain length can be linked to diseases [89], [90].  
The most common analysis method to characterize TAG chain length and saturation relies on 
sample destruction and extraction of all lipids that are then derivatized and separated with gas 
chromatography [214]. In order to couple this chemical to spatial information, three 
techniques can be employed: (i) magnetic resonance imaging (MRI), (ii) matrix-assisted laser 
desorption/ionization mass spectrometry imaging (MALDI-MSI), and (iii) Raman 
microspectroscopy or broadband CARS (BCARS) microscopy. MRI can be applied in variant 
samples in vivo [215], [216] although the resolution of 10 μm (xy) and 100 μm (z) limits it to 
the investigation of bigger lipid depots [217]. Both MALDI-MSI and BCARS rely on fixed 
samples. For BCARS, these are then cut into thin sections (as done in Paper V), while 
MADI-MSI relies the embedding in a complex matrix. The highest resolution achieved with 
the latter technique has been 1.4 μm in mouse brain [218]. The resolution BCARS is in 
principle limited by the diffraction limit at ~ 300 nm [184]. 
BCARS microscopy  
Spectral CARS has been proposed shortly after the development of single frequency CARS 
microscopy [219]–[222]. After data processing the resulting spectra are similar to 
spontaneous Raman spectra, which can generate a chemical fingerprint based on unique 
vibrations found in each molecule and has been used for biological samples [223]. However, 
due to the low signal intensities even in good scatterers, like lipids, it takes around 0.5 s to 
acquire a single spectrum [224]. With the BCARS setup used in Paper IV & V, the 
collection time per pixel can be reduced to 5 ms to acquire a full spectrum between 600 and 
3400 cm-1.  
In order to probe a full BCARS spectrum, typically a broadband Stokes beam is employed 
[225]. The broadband supercontinuum can be generated inside a photonic crystal fiber [226]. 
Often a charge-coupled device (CCD) detector is used, where vertical binning generates a 
linear array of non-negative integers, i.e., signal intensities per wavenumber [179]. A single 
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spectrum is collected in each image point and sample scanning can be performed to acquire a 
spectral map.  
Although the collection of BCARS images is faster than spontaneous Raman spectral images, 
the read out is more challenging due to the contribution of the non-resonant background. This 
non-resonant component is non-frequency dependent and entirely real, while the resonant 
component that contains the chemical information can be divided into a real and imaginary 
part. The imaginary part is directly comparable to spontaneous Raman signals [227]. Both 
display a linear dependence on molecular concentration  [179]:  
𝐼݉{𝜒ோሺଷሻ} =  ܰ  𝐴  𝛤ቀΩ − (𝜔௣ −  𝜔௦)ቁଶ +  𝛤ଶ eq. 6 𝐼ோ௔௠௔௡ ∝  ܰ  𝐴  𝛤ሺΩ − 𝜔଴ሻଶ + 𝛤ଶ  
N is here the number of scatterers, A, Ω, Γ amplitude, frequency, and line width of the 
vibrational mode.  
In order to obtain the imaginary part of 𝜒ோሺଷሻ from raw BCARS spectra, the convolution of the 
resonant and non-resonant components has to be overcome. 𝐼݉{𝜒ோሺଷሻ} can be extracted if the 
spectral phase is known, which can be achieved with a modified Kramers-Kronig relation 
[228]. However, this analysis is technically only applicable to data covering an infinite 
frequency range. In order to extrapolate the data, one method can be the use of a Fourier 
transformation, replacing the negative time domain with a frequency dependent non-resonant 
response, and transforming back to the frequency domain. The relevant mathematical basis to 
this method has been established by Liu, Lee, and Cicerone [229] and is not within the scope 
of this thesis work. For Paper IV & V, the estimation of the frequency dependent non-
resonant response is done either in glass or medium surrounding the samples. Error phase 
correction was achieved either with (i) an iterative noise-maintaining approach [230] 
modified to be model-free with the use of a Savitzky-Golay smoothting filter or (ii) an 
iterative fourth-order polynomic function. Resulting spectra are referred to as Raman-like 
[231].  
TAG chain length and saturation maps in situ (Paper IV & V) 
TAG saturation can be mapped in differentiated 3T3-L1 adipocytes from BCARS spectra 
using the ratio of 1650 cm-1 / 1450 cm-1 [232]. Di Napoli et al. show further that this ratio can 
be used both on phase-retrieved spectra and from raw CARS images along with 2930 cm-1 / 
2885 cm-1 and 3010 cm-1 / 2855 cm-1 [233]. Additionally, the same group has shown that an 
unsupervised factorization approach to decompose chemical components from the Raman-
like spectra generated from BCARS data delivers a lipid spectrum, where the same ratios are 
correlated with the number of double bonds [234]. The disadvantage of this ratio is that only 
one quantity for TAG chemistry, the number of double bonds, is determined while the chain 
length is not taken into consideration. In algae, it has been shown that the 1650 cm-1 / 1450 
Toolbox II: Visualization of LD chemistry 
43 
 
cm- 1 from spontaneous Raman spectra can be correlated with number of double bonds and 
Nc=c/NCH2. This allows then the calculation of the chain length [235]. However, since the data 
is collected with spontaneous Raman spectroscopy, the measurements are slow causing low 
throughput. More promising are methods that employ the full spectrum to obtain information 
about the lipid species. The use of more than two peaks makes the method more robust for 
interferences of other cellular components like protein or nucleic acids. Schie et al. tested 
different least square decomposition of spontaneous Raman spectra for this purpose in an 
hepatic cell line [236]. However, they limit their analysis to oleic and palmitic acid. While 
these two lipid species belong to the most common chains found in AT, the limitation of the 
analysis of only two fatty acids, leaves no room to monitor changes such as the increase of 
chain length and mono-unsaturation that are found in connection with obesity and insulin 
resistance [237].  
Therefore, Paper IV aims to generate a spectral decomposition method that employs the full 
spectral range, but does not make any assumptions about the chains found in the TAGs. First, 
a matrix is generated containing the known spectra of pure TAGs and a generic protein 
coupled to the information about their lipid content, chain length, number of C=C bonds, and 
protein content. The constraint matrix is a 7x4 matrix, which makes the problem 
overdetermined. Thus, the following equation is used for the decomposition:  
 ܯ𝑖݊𝑖݉𝑖𝑧݁ ‖ܵݐܽ݊݀ܽݎ݀ݏ − 𝐶݋݊ݏݐݎܽ𝑖݊ݐݏ  𝑋‖ eq. 7 
In order to solve the equation, an iterative QR factorization of a constrained least square 
problem is employed (MatrixLLS in Igor Wavemetrics). In that way four components can be 
generated of which three represent TAG properties and one the independent protein 
component. The TAG components do not have to be real spectral features, i.e., non-negative, 
since they stem from the same chemical species and are thus expected to have peaks in the 
same locations. Rather, the first component is a general lipid spectrum, while the chain length 
and #C=C components represent spectral changes in defined locations, which can either be 
positive and negative.  
Once the four components have been determined, unknown spectra can be decomposed with 
the following equation:  
 ܯ݁ܽݏሺ݂ሻ =  ܽ ∗ 𝐶்𝐴ீሺ݂ − ଴݂ሻ + ܾ ∗ 𝐶#𝐶=𝐶ሺ݂ − ଴݂ሻ + ܿ ∗ 𝐶#𝐶ுଶሺ݂ − ଴݂ሻ eq. 8  
 + ݀ ∗ 𝐶௣௥௢௧𝑒𝑖௡ሺ݂ − ଵ݂ሻ  + ݉ ∗ ݂ + ݁ 
a, b, c, and d are weights of the four components, f is the Raman shift, and f0 or f1 
respectively allow for slight shifts of lipid and protein components in the measured data 
(Meas). The residual is minimalized with a Levenberg-Marquardt least-squares method 
during the curve fitting.  
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In Paper IV, this method was verified for accurate calculation of average TAG chain length 
and #C=C for pure TAGs, their mixtures, and food oils. For the collection of a BCARS map, 
less than 1 μl sample is required, while for GC separation ~ 500 μl are used. Thus, the 
BCARS method allows a fast estimation of TAG content in liquids, although it does not offer 
the chemical species resolution as obtained with GC and coupled detection, e.g., flame 
ionization detection or mass spectrometry.  
However, a second advantage of this methods is the possibility to explore differences in TAG 
chain length and #C=C in space, as in cells (Figure 18). Here, we found that the error 
increases due to the geometry of the droplets and the difference in refractive index with the 
surrounding aqueous medium (noil = 1.46, nwater = 1.33) [238]. This affects the outer shell of 
the LD, where typically longer chain lengths are found and the number of C=C differs up to 
10% from the center of the droplet. We also noted, that the root mean square error increases 
in biological samples compared to pure oils, which is due to increased samples complexity. In 
conclusion, we found the method to be most suitable for organisms with > 1 μm LDs as 
found in differentiated adipocytes. Thus, this technique is most applicable in mammalian cell 
cultures, tissue sections, plant physiology, and food emulsions. 
The technique developed and characterized in this way was then applied to WAT, BAT, and 
liver slices in Paper V. In order to balance optimal signal strength and avoid sample damage, 
adipose tissue was sliced at lower temperatures than liver (-39°C vs. -14°C) and the proteins 
were crosslinked during thawing to avoid disturbances of the cellular morphology (Figure 
19). This allowed the observation that BAT lipids, similar to liver lipids, assume a 
composition closer to the diet after one week, while iWAT adapts after four weeks.  
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Figure 18. TAG chain length and C=C maps. (A) Integrated symmetric CH2 stretching vibration 
intensity (2845 cm-1) to show LDs in differentiated 3T3-L1 adipocytes. (B) Spatial map of TAG chain 
length and (C) number of C=C bonds. Scale bar: 40 μm. 
 
 
Figure 19. BCARS for sliced tissue. (A) For BCARS measurements, the tissue was snap-frozen, 
sliced (20 μm, at -39°C), fixed (4% para formaldehyde, 150 mM sucrose, 4°C), and then visualized. 
(B) BCARS images contain a third dimension of information, the spectral dimension, where each 
image pixel contains a full BCARS spectrum. From there single wavelengths can be used to visualize, 
e.g., all lipids (magenta, 2845 cm-1). BCARS microscopy can be combined with other methods, e.g., 
SHG (fibrillar collagen, cyan). Scale bar: 40 μm. 
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Surface pattern perturbations of in vitro rat and human ADSC 
(Paper I & II) 
In vivo, stem cells get important cues from both the extra-cellular matrix (ECM) and soluble 
chemical factors that decide, e.g., if they will undergo proliferation, differentiation or 
apoptosis [142], [145], [239], [240]. Due to the intricacy of the natural cellular environment 
these factors remain intertwined and the investigation of these processes in vivo is 
intrinsically circuitous. An impressive amount of materials have been used in an attempt to 
mimic the natural ECM and to influence stem cell fate in both conventional two-dimensional 
(2D) as well as three-dimensional (3D) culture systems as reviewed for example by Dawson 
et al. [241]. With the use of such advanced materials for cell culture, it has been shown that 
not only surface chemistry in both 2D [242], [243] and 3D [244] cell cultures, but also 
physical properties like the elastic modulus [245] or surface topography on nano- [246]–[248] 
and microscale [249]–[251] play an important role in driving cell fate. While much attention 
is devoted to the influence of the matrix on osteogenic differentiation, it has also been shown 
that ADSC need ECM stimulus for soft tissue differentiations towards, e.g., adipocytes 
[252]–[256]. 
In order to fully understand how individual factors influence stem cells in 3D cell cultures, it 
is desirable to work with materials which allow for the independent tunability of biological 
relevant factors, i.e., cell adhesion, matrix stiffness, and matrix topography. Protein 
hydrogels, particularly those made from elastin like peptides (ELPs), offer such control over 
protein properties combined with effective cytocompatibility. ELPs have been inspired by the 
amino acid sequence of elastin, one of the major components of the ECM especially in 
connective tissues [257]. Additionally, bioactive properties can be included into the 
engineered amino acid sequence, i.e., sites for enzymatic degradation [258] and integrin 
specific adhesion [259], e.g., the tripeptide RGD, which is present in fibronectin and other 
ECM matrices [260]. A plasmid equipped with the appropriate sequence allows the 
production of ELP, with desired properties, in bacterial cultures using standard laboratory 
techniques. This results in high batch-to-batch reproducibility, in comparison to natural 
extracted ECM materials, e.g., matrigel, collagen, or alginate, and straightforward scalability. 
Furthermore, ELPs can be formed into hydrogels for cell encapsulation using a chemical 
crosslinked [261]–[265]. My work focused on exploring how features on nano- and 
microscale in soft hydrogels influence adipogenesis of ADSC.  
In order to explore the limitations for surface patterns on ELP hydrogels, in Paper I, we used 
a micro molding approach. The patterns, i.e., 1D and 2D wrinkles, were generated with 
reactive ion edging in polystyrene with wavelengths and depths spanning nano- to micro-
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range [266]. For the transferal of the pattern, an intermediate polydimethylsiloxane (PDMS) 
stamp was used. We could show that on ELP patterns down to 0.37 μm wavelength (pattern 
width: 250 ± 50 nm, height: 50 ± 30 nm) could be imprinted. While smaller patterns could be 
found on the stiffer PDMS (3 MPa [267]) the pattern formation ELP is not only limited by 
the softness (400 kPa) but also by the formation of ELP-rich domains. These domains form 
due to lower-critical solution temperature (LCST) behavior of ELP by transitions above 33°C 
and are ~ 124 – 180 nm.  
In a next step, rat ADSC were subjected to the patterned surfaces and their initial attachment 
was observed. Cell movement and attachment to natural patterned surfaces are especially 
important for cancer cell migration [268], angiogenesis [269], and mechanotransduction 
[270]. The ADSC placed on the aligned scaffolds, start off loosely adherent and move to 
form contact, both with the matrix and with other cells. Such contacts were shown to be 
important for osteogenic [271] and adipogenic [272] differentiation. While the cells adhere 
loosely, they keep their round cell shape and form long cytosolic protrusions to interact with 
the matrix and other cells. However after 12 hours, the cells spread onto the hydrogel surface 
and start to align with the pattern. They still show active migration that is not confined by the 
direction of the pattern. Nevertheless, the pattern direction does initiate the majority of cells 
to orient accordingly, as seen from the alignment of F-actin inside the cytosol after 24 hours 
(Figure 20). The alignment according to the surface topography has been shown with similar 
patterns on PDMS with embryonic stem cells (ESC) [273] and smooth muscle cells [274]. 
Similarly to the smooth muscle cells on PDMS, we found that there is a limit for ADSC to 
sense the surface topography of ELP and align their cytoskeleton. In our case, that limit were 
wrinkles with 0.37 μm wavelength with heights of 50 ± 30 nm, while for the smooth muscle 
cells on PDMS the limit was 0.1 μm wavelength with 20 nm height. The fact that 
higher/wider wrinkles could not be recognized on ELP might be due to the nano-features on 
the wrinkles caused by the ELP-rich aggregates and the large swelling of ELP after 
hydration.  
In Paper II, I went further to investigate the effect aligned or unaligned substrates on the 
adipogenic differentiation of human ADSC. For the purpose of this study, electrospun PCL 
fibers were selected as cell culture matrix due to their ideal prerequisite for diffusion of 
nutrients and oxygen, possibility to trap some of these nutrients, and cytocompatibility. The 
diffusion of nutrients is mainly limited by the pore sizes found in ECM-mimicking materials 
and can then lead to apoptosis if the cells are undersupplied [275]. Due to shallow depth of 
the PCL fiber substrates (10-20 μm), the diffusion should not be limited. Additionally, we 
found that the cells rather attach on top of the matrix than inside (Figure 21), which lead us 
to classify the culture as 2.5D (a system between 2D and 3D stem cell cultures [276]), similar 
to the wrinkled hydrogels (Paper I). Although PCL has no cell adhesion sites, in contrast to 
ELP, both materials are hydrophobic, which means that proteins from serum added to the cell 
culture medium form hydrophobic interactions with the matrix, slowing their diffusion, and 
therefore helping the stem cells with nutrient uptake [277] and attachment. Lastly, PCL has 
shown biocompatibility and is a Food and Drug Administration (FDA) approved material for 
the use in humans as a contraceptive barrier [277].  
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Figure 20. Alignment of rADSC. Stem cells align on (A) wrinkles with 0.60 μm in wavelength with 
130 ± 40 nm height, but not on (B) with 0.37 μm wavelength with 50 ± 40 nm height. Hydrated ELP 
(blue, CARS, 2930 cm-1), nuclei (red, MPEF, Hoescht34580), F-Actin (green, MPEF, Alexa488-
Phalloidin). (C, D) Schematics of the typical cell shape on these patterns (dry ELP, grey, AFM). Cells 
are not in scale. Scale bars: 40 and 5 μm.  
 
Figure 21. hADSC differentiated for 14 days on PCL. (A-C) Unaligned PCL fibers: (A) sum over full 
thickness of the z-stack. (B) Some cells are between the fibers, (C) while other cells are on top of the 
matrix. (D-F) Aligned PCL fibers: (D) sum over full thickness of the z-stack. (E) Some cells are on top 
of the fibers, (F) and a second layer forms on top of these cells. Lipids (magenta, CARS, 2845 cm-1), 
intrinsic fluorescence (blue, MPEF), estimated cell outlines (white). Scale bars: 25 μm. 
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Furthermore, PCL containing matrices have been used to enhance adipogenesis/ 
chondrogenesis [278] and electrospun matrices have been used for adipogenesis of ESC 
[279].  
By using aligned or unaligned PCL fiber matrices we found an effect on maturation during 
adipogenesis. When comparing lipid accumulation, we found more lipids in cells grown on 
aligned fibers, while the cells grown on both matrices display larger LDs, than the cell culture 
plastic control (Paper II). However, in all of the evaluated systems, there are multiple LDs 
per cell, in contrast to the unilocular LDs found in mature adipocytes in vivo. Yet more 
crucial than morphology, is the functionality of the differentiated stem cells. We aimed for a 
more mature phenotype, and used isolated mature adipocytes as a comparison. Here, we 
found the dose response curve of insulin-stimulated glucose uptake to be closer to mature 
adipocytes in both fiber matrices than the 2D control. While the cells on the unaligned fibers 
showed the highest glucose uptake upon stimulation, they also show a high basal uptake, 
which does not mimic the behavior of the mature cells. Thus, the aligned fibers produce the 
cells which resemble the mature adipocytes the most. While we did not find differences in 
gene expression or lipolysis, we still believe the cells differentiated on the aligned fiber 
matrix to be one step closer to a functional in vitro model of adipogenesis than the 2D 
control.  
Summarizing from the in vitro studies in Paper I & II and other unpublished results, it can 
be remarked that the modelling of in vivo function is a complex challenge. At the same time, 
from these in vitro studies, new mechanistical insights into and material systems for stem cell 
differentiation and advanced analysis techniques can be developed for application in vivo.  
 
Genetic perturbations of in vivo mouse adipocytes (Paper III) 
While in vitro cultures allow unique insight into isolated adipocyte function, in vivo systems 
can shed light on mechanisms connecting all the organs involved during the development of 
obesity and its connected diseases. Already in the 1950s, it was proposed that obesity is not 
purely linked to positive energy balance cause by behavior alone but that genetic factors also 
play a role [280]. However, gene expression or mutations are a challenging target for drugs 
[280], thus cell signaling trough, e.g., protein kinases or phosphatases might be a more 
promising target [281]. Several kinases have been described for the function of WAT [282], 
BAT [42], and in connection with obesity/insulin resistance [283].  
One serine/threonine protein kinase (STK)25, part of the sterile 20 (STE20) kinase 
superfamily [284], has been identified as a regulator for lipid partitioning, and systemic 
insulin and glucose homeostasis in mice and humans [285]–[293]. Paper III is based on the 
observation that STK25 mRNA and protein is found both in BAT and WAT [285], [286], 
[288], and therefore might be involved in the adipocyte dysfunction seen during obesity. To 
investigate this link, high-fat diet (HFD) fed Stk25 transgenic and knockout mice [286], [294] 
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were compared to their corresponding wild-type (WT) littermates. Three AT depots were 
investigated: interscapular BAT, and inguinal/subcutaneous WAT and 
(peri)gonadal/epididymal WAT (in the paper referred to as sWAT/eWAT, in this thesis 
referred to as iWAT/gWAT). In the transgenic (TG) mice overexpressing Stk25 HFD-induced 
lipid accumulation, inflammation, and fibrosis are aggravated. Specifically, with a 
combination of CARS for lipids and MPEF for active mitochondria stained with 
rhodamine123 (Rho123), we could observe that the cellular mitochondrial activity decreases 
while the lipid content increases. This is also qualitative visible from more unilocular LDs in 
BAT and lower Rho123 fluorescence. In iWAT/gWAT the same trends are found. These 
observations are further confirmed with MitoTracker Red staining (active mitochondria) and 
ATGL/HSL activity (inverse correlation with lipid content). In the knockout (KO) mice that 
are depleted of STK25 protein, a protective effect against HFD-induced changes could be 
observed instead. In the STK25-KO, the mitochondrial activity increased and the lipid 
content decreased against WT littermates. The depletion of STK25 protein was further 
simulated using Stk25 siRNA in brown, HIB-1B, and white, 3T3-L1, adipocyte cell lines. In 
the transfected HIB-1B cells lipid accumulation was reduced, and ȕ-oxidation and 
mitochondria area augmented. However, no change in fatty acid influx or storage in TAG 
was observed. LD size was also reduced in the transfected 3T3-L1 adipocytes. These findings 
on in vitro adipocytes combined with the in vivo pathology, leads to the conclusion that 
altered mitochondrial activity might be central to the role of STK25 in ATs. Interestingly, a 
downregulation of mitochondrial activity has been found in obese humans with decreased 
fatty acid oxidation and linked to insulin resistance [295].  
 
Nutritional perturbations of in vivo mouse adipocytes (Paper V) 
The regular consumption of certain foods has been linked with an increased risk for obesity 
and diabetes, e.g., foods/drinks with added sweeteners [296]–[298]. Further, a data analysis 
study on 48 170 white European adults suggest an impact of total fat consumption, and more 
so the consumption of saturated fat, on the BMI [299]. In fact, not only the absence of 
carbon-carbon double bonds in TAGs but also the exact location of existing double bonds 
seems to play a role on the human metabolic health [300]–[302]. In C57BL/6J mice, obesity 
can be induced with a HFD [303]. As discussed in Chapter 2, there are two pathways for the 
generation of TAGs: (i) de novo lipogenesis or (ii) direct esterification of FAs. The main sites 
for both processes are liver and AT. While diet induced changes in WAT [304], [305] and 
liver [306] have been explored extensively, the role of BAT is more elusive. It has been 
found that BAT mass increases in the early stages of weight gain in mice [307], that BAT is 
involved in the short-term clearance of TAGs in the postprandial period [53], and that the 
TAG chemistry in BAT changes upon arousal from hibernation [308].  
In Paper V, we followed the changes of TAG chemistry after one and four weeks of HFD 
using the BCARS method established in Paper IV. Additionally, we tracked changes on a 
gene expression level. Already after one week of HFD, mice showed increases in LD size in 
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BAT, iWAT, gWAT, and liver, compared to littermates fed chow diet (CD) (Figure 22). In 
BAT, this results in a shift from multilocular to unilocular LDs (42.2x increase in volume), an 
observation that has previously been described as ‘whitening’ of BAT and linked to a loss in 
function [309]. After four weeks of HFD intervention, the fold increase in LD size is less 
pronounced (3.3x) while there transition from multilocular to unilocular remains. Along with 
changes in LD diameter, we also found changes in expression of genes involved in de novo 
lipogenesis after one week in BAT and liver. In iWAT the adaptation of genetic expression 
becomes only significant after four weeks. The observed changes in gene expression indicate 
that do novo lipogenesis is reduced under HFD. Although similarly to other studies, we find a 
restoration of the expression of these genes in liver under HFD, which has been previously 
linked to a remodelling of hepatic fatty acids rather than de novo lipogenesis under HFD 
[310]. Still, the downregulation of these genes indicate that changes in TAG chemistry are 
more likely to result from uptake of dietary fatty acids. On average, the diet provides more 
unsaturated fatty acids than the chains found in all the tissues. In both BAT and liver, more 
unsaturated TAG chains are observed after one week of HFD (Figure 22), while for iWAT 
this increase only occurs after four weeks of HFD. It has been previously found that not all 
dietary fatty acids are taken up equally, rather there is a preference in monounsaturated and n-
6 polyunsaturated fatty acids in human iWAT [311], which could be an behind the increase of 
unsaturation under HFD. If all data is considered, it can be hypothesized that BAT and liver 
behave similarly and due to their relatively faster metabolism they are responsible to deal 
with the initial lipid load, while iWAT has a slower adaptation rate and thus adapts slowly 
over to increase long term storage of lipids under prolonged HFD. However, if the lipid load 
from the diet remains high, WAT cannot store all the lipids, which leads to ectopic lipid 
depositions in liver and muscle [312], and speculatively also BAT. The initial role for lipid 
buffering as hypothesized for BAT and liver, can be also seen from data which follow lipid 
accumulation in liver over time and show that the accumulation is not a linear process but 
rather spikes after short term interventions, decreases intermediately (4 weeks in mice), and 
then increases again [306]. 
Nutritional perturbations of in vivo mouse adipocytes (Paper V) 
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Figure 22. TAG unsaturation in lipid tissues. (A, D), iWAT, (B, E) BAT, and (C, F) liver after one 
week CD (top row) or one week HFD (bottom row). Changes in gWAT are analogous to iWAT. Lipids 
(2845 cm-1, CARS): orange ~ 0.5 double bonds per TAG molecule, green: ~0.7 – 0.8, fibrillar collagen 
(SHG, cyan). Schematics show LDs inside the cells. Scale bars: 25 μm 
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The focus on AT function in health and disease has increased due to the rise in rates of obese 
individuals. Especially with the discovery of brown and beige adipocytes in adult humans, 
the field has received increased traction and interest. However, with growing understanding 
of AT function, the number of unaddressed questions seems to increase and the need for new 
analytical techniques has expanded. The research presented in this thesis, focuses on the gap 
of chemical biology analytical techniques for investigating of AT and cells in various 
contexts as related to development and pathology in situ.  
Methods development 
In Paper I & II, single frequency CARS microscopy is applied both to study living ADSC in 
interaction with soft and hydrated ECM-mimicking. Furthermore, the accumulation of LDs in 
individual cells on top of an analytical interfering matrix has been demonstrated in Paper II. 
This application can then be extended to living adipocytes in ex vivo tissue in Paper III. 
Since single frequency CARS microscopy does not require thin slices, the lipids in the 
adipocytes remain unperturbed in contrast to many other methods. Especially in white 
adipocytes with small cytosolic volume, a bursting of the cells will also result in a 
displacement of other organelles, which hinders the study of in vivo cell morphology. With 
the LDs contained inside the adipocytes, a mitochondrial activity staining was also added to 
simultaneously monitor the primary organelles involved in energy storage and expenditure. 
In a next step, we extended the analysis to include information on TAG chemistry in addition 
to adipocyte morphology. For that purpose, we characterized a method for spectral fitting of 
Raman-like spectra, collected with BCARS microscopy, from TAGs as demonstrated in 
Paper IV. We could show the acquisition of TAG chain length and number of C=C bonds 
maps for various model systems In contrast to most previous studies, we employ a broad 
spectral range to increase the robustness of the method.  
Biological applications 
Spectroscopic methods are often developed as a proof-of-concept, and it takes a long time 
before they are applied to answer interdisciplinary scientific questions. CARS microscopy 
has only in the recent years been employed for a broad range of material science, biological, 
and clinical questions, as a result of the developments of commercial microscopes, increased 
outreach, and interdisciplinary collaboration. Therefore, it has been of special interest in this 
thesis work to not only develop methods, but also to apply them within the field of adipocyte 
biology in model systems with different complexity.  
Paper I follows the initial attachment ADSC on a wrinkled hydrogel substrate, where they 
align their cytoskeleton according to the wrinkle direction. There is a lower size limit for 
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structures on which the cells align and on matrices where the cells align, their migration 
direction is not uniaxial. Paper II adds to these results by showing that an aligned substrate 
can induce a more mature functional phenotype in adipogenic-differentiated ADSC. These 
findings are in line with other studies showing that ADSC are mechanosensitive and might be 
of relevance to the changes in ECM that occur during obesity. Moreover, studying stem cell 
differentiation in vitro and in vivo might add to the understanding of AT expansion during 
weight gain 
While certain questions can be fully answered using isolated cultures of adipocytes, in Paper 
III & V we focused on mouse whole body adjustments to genetic or nutritional perturbations, 
respectively. The increased or decreased expression of Stk25 can cause whole-body 
disruptions upon high-fat feeding and in AT specifically, we observed an effect on 
mitochondrial activity and cellular lipid content (Paper III). The presented data leads to the 
conclusion the Stk25 might act via interference with the mitochondrial ȕ-oxidation. While 
these findings indicate a possible target to decrease the effects of HFD feeding, we also 
aimed to further the understanding how HFD feeding affects lipid containing tissue. 
Therefore, in Paper V we follow the changes of TAG chain length and saturation in the early 
stages of HFD stimulation. BAT is affected in a similar fashion by HFD as liver, points 
towards an involvement of both tissues in the initial clearance of increase lipid influx. WAT, 
which typically stores excess TAGs, adapts at a slower rate to the HFD feeding.  
Future directions 
In summary, this thesis situated at the interface of physics, material science, and biology, 
demonstrates the application of advanced microscopy techniques to current biological 
challenges. As obvious from the number of papers not included in this thesis work, there is a 
multitude of scientific questions that can be addressed, especially in a collaborative research 
environment. Since research is a dynamic progress, there have been unfinished projects and a 
number of new questions along the way.  
In a continuation of the work presented in this thesis, the most scientifically relevant and 
interesting direction would be towards in vivo experiments with samples from humans. 
However, they are limited in availability and require both strict ethical considerations and 
experimental planning. An interesting method to consider in this context might be coherent 
Raman endoscopy [313]. Further, since the BCARS method used in Paper IV & V needs 
only small amounts of sample, it would be possible to work with human AT biopsy samples. 
An interesting experimental outline would be the comparison of TAG chemistry, adipocyte 
morphology, and gene expression of BAT and WAT in metabolically healthy obese, obese 
with metabolic syndrome, and a lean control group. If the samples could be collected in a 
hospital close to a CARS microscope, it would additionally be possible to employ the 
mitochondrial activity staining as shown in Paper III. However, while such an experiment 
would certainly unravel details about human AT physiology, the groups would at the same 
time be difficult to match and patient-to-patient variability might outweigh changes induced 
by metabolic health.  
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Thus, in a more practical context it would be exciting to take the in vitro results from Paper I 
& II into 3D. Especially, beige/brown adipogenesis has not been extensively mimicked in 
cell cultures, although there is some indication that hydrogel encapsulation can enhance ESC 
differentiation towards brown/beige adipocytes [314]. Considering, that obesity leads to an 
ECM-remodeling, a matrix with tunability of biological properties allows for increased 
control over experimental factors. This increased control, along with ethical considerations 
about the use of animals, is the main advantage of in vitro systems, while in vivo experiments 
reveal interactions and pathological changes. Along the course of my PhD project, I have 
worked with several promising 3D matrices, which could be used for adipogenesis (Figure 
23): porous ELP hydrogels, collagen hydrogels with different fiber morphology, and 
decellularized AT. The latter has successfully been used to drive white adipogenesis of 
hADSC [253], [315]. The main challenges in 3D matrices are the perfusion of nutrients and 
possibly a low number of cells that are encapsulated in the matrix. Due to the 3D nature of 
the system, nonlinear microscopy as evaluation tool can be of increased use and provide 
value in combination with studies on cellular function.  
Personally, I find the latter aspect the most intriguing, i.e., to advance the developed methods 
so they can be applied to functional studies. One example of a functional study would be the 
observation of lipolysis in real time from either cultured cells or intact tissue samples. 
Further, it might be possible to follow ‘browning’ of cultured white adipocytes over time, i.e., 
follow changes in lipid morphology and mitochondrial activity. An additional project, which 
I personally would like to pursue, is the uptake of fatty acids in cultured white and 
beige/brown adipocytes to see if our in vivo findings can be replicated in vitro where added 
clues about the role of BAT in lipid clearance could be established.  
 
Figure 23. 3D matrices. (A) Microporous ELP, (B, C) collagen hydrogels formed at 20°C (B) or 37°C 
(C), (D-G) decellularized WAT (D, E) or BAT (F, G) from rat. Hydrated ELP (blue, CARS, 2930 cm-1), 
fibrillar collagen (cyan, SHG), lipids (magenta, CARS, 2845 cm-1), intrinsic fluorescence (red, MPEF). 
(A, E, G) 3D renderings. Scale bars: 100, 10, and 50 μm.  
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